Form 10-K/A
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K/A
Amendment No. 1
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the Fiscal Year Ended December 31, 2008
Commission File Number 1-5620
Safeguard Scientifics, Inc.
(Exact name of Registrant as specified in its charter)
|
|
|
Pennsylvania |
|
|
(State or other jurisdiction of
|
|
23-1609753 |
incorporation or organization)
|
|
(I.R.S. Employer ID No.) |
|
|
|
435 Devon Park Drive |
|
|
Building 800 |
|
|
Wayne, PA
|
|
19087 |
(Address of principal executive offices)
|
|
(Zip Code) |
(610) 293-0600
(Registrants telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
Title of Each Class
|
|
Name of each exchange on which registered |
Common Stock ($.10 par value)
|
|
New York Stock Exchange |
Securities registered pursuant to Section 12(g) of the Act:
None
Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule
405 of the Securities Act.
Yes o No þ
Indicate by check mark if the Registrant is not required to file reports pursuant to Section
13 or Section 15(d) of the Exchange Act. Yes o No þ
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the Registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the registrant has submitted electronically and posted on its
corporate Web site, if any, every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period
that the registrant was required to submit and post such files). Yes o No o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation
S-K is not contained herein, and will not be contained, to the best of Registrants knowledge, in
definitive proxy or information statements incorporated by reference in Part III of this Form 10-K
or any amendment to this Form 10-K. þ
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large
accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the
Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer o
|
|
Accelerated filer þ
|
|
Non-accelerated filer o
|
|
Smaller Reporting Company o |
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of
the Exchange Act).
Yes o No þ
As of June 30, 2008, the aggregate market value of the Registrants common stock held by
non-affiliates of the registrant was $149,773,608 based on the closing sale price as reported on
the New York Stock Exchange.
The number of shares outstanding of the Registrants Common Stock, as of April 15, 2009 was
122,029,312.
TABLE OF CONTENTS
Explanatory Note
Explanatory Note
Safeguard Scientifics, Inc. (Safeguard, the Company, we, us, and our) is filing this
Amendment No. 1 on Form 10-K/A for the year ended December 31, 2008 (Form 10-K/A) to amend our
Form 10-K for the year ended December 31, 2008, filed with the Securities and Exchange Commission
(the SEC) on March 19, 2009 (the Original 10-K). The Company is hereby amending the Form 10-K
as follows:
|
|
To include Part III of the Original 10-K in its entirety, which items were originally
expected to be incorporated by reference in our definitive proxy statement to be delivered to
our shareholders in connection with our 2009 annual meeting of shareholders; and |
|
|
On the cover page, (i) to delete the reference in the Original 10-K to the incorporation by
reference of the Companys proxy statement for its 2009 annual shareholders meeting and
(ii) to update the date as of which the number of outstanding shares of the Companys common
stock is being provided. |
This
Form 10-K/A does not reflect events that occurred after the filing of
the Original 10-K. As a result of this amendment, we also are filing
the certifications pursuant to Section 302 of the Sarbanes-Oxley Act
of 2002 as exhibits to this Form 10-K/A. These certifications are
included as Exhibits 31.3 and 31.4.
Except for the amendments and updates described above, this Form 10-K/A does not
modify or update in any other way the Original 10-K.
PART III
Item 10. Directors, Executive Officers and Corporate Governance
Directors
The members of the Board of Directors of the Company, as of the date of this Form 10-K/A, are as
follows:
Peter J. Boni, age 63, joined Safeguard as President and Chief Executive Officer and a member of
the Board in August 2005. Mr. Boni also is a director of Clarient, Inc. Positions held include
Operating Partner for Advent International, Inc., a global private equity firm with $10 billion
under management (April 2004 to August 2005); Chairman and Chief Executive Officer of Surebridge,
Inc., an applications outsourcer serving the mid-market (March 2002 to April 2004); Managing
Principal of Vested Interest LLC, a management consulting firm (January 2001 to March 2002); and
President and Chief Executive Officer of Prime Response, Inc., an enterprise applications software
provider (February 1999 to January 2001).
Michael J. Cody, age 59, has served on our Board since 2006. Positions held include Senior Vice
President of Corporate Development (November 2007 to March 2009) of Ensign-Bickford Industries, a
provider of ordnance initiation systems for the aerospace and defense industries, chemical
processing, renewable energy and pet food palatability products; Partner, Meadowood Capital, LLC, a
private equity firm (April 2007 to November 2007); Vice President of Corporate Development,
responsible for mergers, acquisitions and divestitures at EMC Corporation, a provider of products,
services and solutions for information storage and management (1998 until his retirement in March
2007); Director of Corporate Development at United Technologies Corporation, a diversified
technology company (1993 to 1998); Managing Director of the investment banking group at Price
Waterhouse (1990 to 1993); and Vice President of Investment Banking at Kidder Peabody & Co. (1980
to 1989).
Julie A. Dobson, age 52, has served on our Board since 2003. Ms. Dobson also is a director of
PNM Resources, Inc. and non-executive Chairperson of the Board of LCC International, Inc.
Positions held include Chief Operating Officer (1998 until February 2002) of TeleCorp PCS, Inc., a
wireless/mobile phone company that was acquired by AT&T Wireless, Inc. in late 2001; President of
Bell Atlantic Corporations New York/ New Jersey Metro Region mobile phone operations (1997 to
1998); and a number of executive positions during her 18-year career with Bell Atlantic
Corporation, including sales, operations, and strategic planning and development in the chief
executive officers office.
Robert E. Keith, Jr., age 67, has served on our Board since 1996 and was appointed Chairman of the
Board in October 2001, prior to which he served as Vice Chairman since February 1999. Mr. Keith
also is a director of Internet Capital Group, Inc. Positions held include Managing Director of TL
Ventures, a group of venture capital funds, and its predecessor funds (1988 to present); senior
adviser to, and co-founder of, EnerTech Capital Partners (1996 to present); member of the Office of
the Chief Executive of Safeguard (April 2001 to October 2001); and President (1991 to December
2002) and Chief Executive Officer (February 1996 to December 2002), of Technology Leaders
Management, Inc., a private equity capital management company.
Andrew E. Lietz, age 70, has served on our Board since 2003. Mr. Lietz also is a director of
Amphenol Corporation and DDi Corp. Positions held include Managing Director and Founder of Rye
Capital Management, LLC, a private equity investment firm (2001 to present); Executive Chairman
(late 2000 until mid 2002) of Clare Corporation, a designer and manufacturer of integrated
circuits, solid-state relays and electronic switches, which was acquired by Ixys Corporation in
June 2002; President and Chief Executive Officer (1995 to 2000) of, and several other executive
positions during his 16-year career with, Hadco Corporation, a global manufacturer of electronic
interconnect products and services; and a variety of positions at IBM Corporation.
1
George MacKenzie, age 60, has served on our Board since 2003. Mr. MacKenzie also is a director of
American Water Works Company, Inc., C&D Technologies, Inc. and Tractor Supply Company. Positions
held include non-executive Chairman of the Board (May 2006 to present) and interim Chief Executive
Officer (January 2006 to April 2006) of American Water, a provider of water services in North
America; interim Chief Executive Officer of C&D Technologies, Inc., a technology company that
produces and markets systems for the conversion and storage of electrical power (March 2005 to July
2005); Executive Vice President and Chief Financial Officer of P.H. Glatfelter Company, a
manufacturer of specialty papers and engineered products (September 2001 to June 2002); Vice
Chairman (2000 to 2001) and Chief Financial Officer (1995 until his retirement in 2001) of, and
several other executive positions during his 22-year career with, Hercules, Incorporated, a global
chemical specialties manufacturer.
George D. McClelland, age 62, has served on our Board since 2006. Mr. McClelland also is a
director of Wave Systems Corp. Positions held include Chairman, CEO and Founder of eSecLending, a
provider of securities lending services to the pension industry (2000 to 2001); a director of
Riverstone Networks, Inc. and Storage Networks, Inc.; Senior Vice President, responsible for
managing many of the portfolio companies of United Asset Management Corporation, a public holding
company (1994 to 2001); multiple corporate management roles at FMR Corp., a diversified financial
services company (1987 to 1991); and Corporate Treasurer of Data General Corporation, a technology
company (1972 to 1987).
Jack L. Messman, age 69, has served on our Board since 1994. Mr. Messman also is a director of AMG
Advanced Metallurgical Group N.V., RadioShack Corporation and Timminco Limited. Positions held
include Chairman of the Board and Chief Executive Officer of Novell, Inc., a provider of
infrastructure software products focused around Linux and identity management (2001 to 2006); Chief
Executive Officer and President of Cambridge Technology Partners (Massachusetts), Inc., an
e-business systems integration company (August 1999 until its acquisition by Novell, Inc. in July
2001); Chairman and Chief Executive Officer of Union Pacific Resources Group Inc., an independent
oil and gas exploration and production company (April 1991 to August 1999); and Chairman and Chief
Executive Officer of USPCI, Inc., Union Pacifics environmental services company (May 1988 to April
1991).
Dr. John W. Poduska, Sr., age 71, has served on our Board since 1987. Dr. Poduska also is a
director of Novell, Inc. and Anadarko Petroleum Corporation. Positions held include Chairman of
Advanced Visual Systems, Inc., a provider of visualization software and solutions (January 1992 to
December 2001); President and Chief Executive Officer of Stardent Computer, Inc, a computer
manufacturer (December 1989 to December 1991); and Founder, Chairman and Chief Executive Officer of
Stellar Computer, Inc., a computer manufacturer and the predecessor of Stardent Computer, Inc.
(December 1985 to December 1989).
John J. Roberts, age 64, has served on our Board since 2003. Mr. Roberts also is a director of
Armstrong World Industries, Inc. and Vonage Holdings Corp. and a trustee of Pennsylvania Real
Estate Investment Trust. Mr. Roberts is a C.P.A. Positions held include Global Managing Partner
and a Member of the Leadership Team of PricewaterhouseCoopers LLP at the time of his retirement in
June 2002, completing a 35-year career with the professional services firm during which he served
in a variety of client service and operating positions.
Dr. Robert J. Rosenthal, age 52, has served on our Board since 2007. Positions held include
President, Chief Executive Officer and a director of Magellan Biosciences, Inc., a provider of
clinical diagnostics and life sciences research tools (October 2005 to present); President, Chief
Executive Officer and a director of TekCel, Ltd., a provider of life sciences research tools
(October 2003 to January 2007); President and Chief Executive Officer of Boston Life Sciences,
Inc., a diagnostic and therapeutic development company (July 2002 to October 2003); President and
Chief Executive Officer of Magellan Discovery Technologies, LLC, a life sciences acquisition
company (January 2001 to July 2002); Senior Vice President of PerkinElmer Corporation and President
of its instrument division (March 1999 to November 2000); and in various executive positions at
Thermo Optek Corporation (September 1995 to February 1999).
2
Executive Officers
The information with respect to executive officers required by this item is set forth in Annex to
Part I of this report.
Section 16(a) Beneficial Ownership Reporting Compliance
Section 16(a) of the Securities Exchange Act of 1934 requires our directors, executive officers and
greater than 10% holders of our common stock to file with the SEC reports of ownership of our
securities and changes in ownership of our securities. Based solely on our review of the copies of
reports we have received and upon written representations from the reporting persons that no Form 5
reports were required to be filed by those persons, Safeguard believes there were no late filings
by our directors and executive officers during 2008. There were no known holders of greater than
10% of our common stock during 2008.
CORPORATE GOVERNANCE AND BOARD MATTERS
Safeguards Corporate Governance Guidelines, Code of Business Conduct and Ethics, and the charters
for the Boards Audit Committee, Compensation Committee and Nominating & Corporate Governance
Committee are available at www.safeguard.com/governance. Shareholders also may obtain a print
copy of these documents, at no cost, by writing to our Secretary at 435 Devon Park Drive, Building
800, Wayne, PA 19087-1945. The Code of Business Conduct and Ethics is applicable to all employees
of Safeguard, including each of our executive and financial officers, and the members of our Board.
Safeguard intends to post information regarding amendments to or waivers from our Code of Business
Conduct and Ethics (to the extent applicable to Safeguards directors or executive officers) in the
Corporate Governance section of our website. Our website is not part
of this Form 10-K/A. All
references to our website address are intended to be inactive textual references only.
Board Independence. Safeguards common stock is listed on the New York Stock Exchange, which we
refer to below as the NYSE. To assist the Board in making independence determinations, the Board
has adopted categorical standards which are reflected in our Corporate Governance Guidelines.
Generally, under these standards, a director does not qualify as an independent director if any of
the following relationships exist:
|
|
Currently or within the previous three years, the director has been employed by us; someone
in the directors immediate family has been one of our executive officers; or the director or
someone in the directors immediate family has been employed as an executive officer of
another company where any of our present executive officers at the same time serves or served
on that companys compensation committee; |
|
|
|
The director is a current partner or employee, or someone in the directors immediate
family is a current partner of, a firm that is our internal or external auditor; someone in
the directors immediate family is a current employee of the firm and personally works on our
audit; or the director or someone in the directors immediate family is a former partner or
employee of such a firm and personally worked on our audit within the last three years; |
|
|
|
The director or someone in the directors immediate family received, during any 12-month
period within the last three years, more than $120,000 in direct compensation from us (other
than director and committee fees and pension or other forms of deferred compensation for prior
service that are not contingent in any way on continued service); |
|
|
|
The director is a current employee or holder of more than 10% of the equity of another
company, or someone in the directors immediate family is a current executive officer or
holder of more than 10% of the equity of another company, that has made payments to or
received payments from us, in any of the last three fiscal years of the other company, that
exceeds the greater of $1 million or 2% of such other companys consolidated gross revenues;
or |
|
|
|
The director is a current executive officer of a charitable organization to which we have
made charitable contributions in any of the charitable organizations last three fiscal years
that exceed the greater of $1 million or 2% of that charitable organizations consolidated
gross revenues. |
The Board has determined that Michael Cody, Julie Dobson, Andrew Lietz, George MacKenzie, George
McClelland, Jack Messman, John Poduska, John Roberts and Robert Rosenthal have no direct or
indirect material relationships with us other than their directorship and, therefore, are independent within the
meaning of the NYSE listing standards and satisfy the categorical standards contained in our
Corporate Governance Guidelines.
3
Board Structure and Committee Composition. At the date of this Form 10-K/A, Safeguards Board has
11 members and five current committees. The Board held nine meetings in 2008. Each incumbent
director attended at least 75% of the total number of meetings of the Board and committee(s) of
which he or she was a member. Directors are invited, but not required, to attend annual meetings
of Safeguard shareholders. Ten directors attended our 2008 annual meeting of shareholders. Under
our Corporate Governance Guidelines and NYSE listing standards, non-employee directors meet in
executive session at each regularly scheduled Board meeting, outside of the presence of any
management directors and any other members of Safeguards management who may otherwise be present,
and during at least one session per year, only independent directors are present. The Chairperson
of the Nominating & Corporate Governance Committee presides at these sessions. The table below
describes the membership of each of the current committees during 2008 and the number of meetings
held by each of these committees during 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nominating & |
|
|
|
|
|
|
|
|
|
|
Corporate |
|
Strategy |
|
|
Acquisition |
|
Audit |
|
Compensation |
|
Governance |
|
Committee |
Number of Meetings held in 2008 |
|
3 |
|
16 |
|
9 |
|
4 |
|
3 |
Membership: |
|
|
|
|
|
|
|
|
|
|
Peter J. Boni |
|
ü |
|
|
|
|
|
|
|
ü |
Michael J. Cody |
|
ü |
|
|
|
|
|
ü |
|
ü |
Julie A. Dobson |
|
|
|
|
|
Chairperson |
|
|
|
|
Robert E. Keith, Jr. |
|
Chairperson |
|
|
|
|
|
|
|
|
Andrew E. Lietz |
|
|
|
|
|
|
|
Chairperson |
|
|
George MacKenzie |
|
|
|
Chairperson |
|
|
|
|
|
|
George D. McClelland |
|
|
|
ü |
|
ü |
|
|
|
Chairperson |
Jack L. Messman |
|
ü |
|
|
|
|
|
ü |
|
|
John W. Poduska, Sr. |
|
ü |
|
|
|
|
|
ü |
|
ü |
John J. Roberts |
|
|
|
ü |
|
ü |
|
|
|
|
Robert J. Rosenthal |
|
ü |
|
ü |
|
|
|
|
|
ü |
Acquisition Committee. The Board has delegated to the Acquisition Committee the authority to
approve, between regularly scheduled Board meetings, the following transactions:
|
|
Follow-on transactions in existing partner companies involving amounts between $5 million
and $20 million; |
|
|
|
New transactions involving amounts between $10 million and $20 million; and |
|
|
|
Divestitures of existing partner companies involving amounts between $10 million and $20
million. |
Audit Committee. The Audit Committees responsibilities, which are described in detail in its
charter, include, among other duties, the responsibility to:
|
|
Assist the Board in fulfilling its responsibilities regarding general oversight of the
integrity of Safeguards financial statements, Safeguards compliance with legal and
regulatory requirements, and the performance of Safeguards internal audit function; |
|
|
|
Interact with and evaluate the performance, qualifications and independence of Safeguards
independent registered public accounting firm; |
|
|
|
Review and approve related party transactions; and |
|
|
|
Prepare the report required by SEC regulations to be included in the proxy statement. |
The Audit Committee has the sole authority to retain, set compensation and retention terms for,
terminate and oversee the relationship with Safeguards independent registered public accounting
firm (which reports directly to the Audit Committee). The Audit Committee also oversees the
activities of the internal auditor, reviews the effectiveness of the internal audit function and
approves the appointment of the internal auditor. The Audit Committee has the authority to obtain
advice, counsel and assistance from internal and external legal, accounting or other advisors as
the Audit Committee deems necessary to carry out its duties and to
receive appropriate funding from Safeguard for such advice and assistance. The full responsibilities of the Audit Committee
are set forth in the Audit Committee Charter, which is reviewed annually by the Committee. The
Audit Committee Charter is available through the Corporate Governance link on our website at
www.safeguard.com/governance.
4
The Board has determined that each member of the Audit Committee meets the independence
requirements established by SEC regulations, the NYSE listing standards and by our Corporate
Governance Guidelines. The Board has determined that Messrs. MacKenzie, McClelland and Roberts and
Dr. Rosenthal are audit committee financial experts within the meaning of the SEC regulations,
and the Board has determined that each member of the Audit Committee has accounting and related
financial management expertise within the meaning of the NYSE listing standards. Mr. MacKenzie and
Mr. Roberts each serve as a member of the audit committee of the board of directors of four
publicly traded companies, including our Audit Committee. The Board has determined that such
simultaneous service does not impair Mr. MacKenzies or Mr. Roberts ability to effectively serve
on our Audit Committee.
Compensation Committee. The Compensation Committees responsibilities, which are described in
detail in its charter, include, among other duties, the responsibility to:
|
|
Approve the philosophy for compensation of our executives and other employees; |
|
|
|
Establish compensation (including base salary, incentive compensation and equity-based
programs) for our Chief Executive Officer and other executive officers; |
|
|
|
Administer the long- and short-term compensation and performance-based incentive plans
(which are cash and equity based); |
|
|
|
Approve employment agreements and perquisites provided to our executive officers; |
|
|
|
Review managements recommendations for our broad-based employee benefit plans; |
|
|
|
Evaluate and recommend to the Board the compensation for all non-employee directors for
service on the Board and its committees; and |
|
|
|
Review and discuss with management the Compensation Discussion and Analysis and recommend
to the Board its inclusion in our Form 10-K and proxy statement. |
The Compensation Committee Charter is available through the Corporate Governance link on our
website at www.safeguard.com/governance. The Board has determined that each member of the
Compensation Committee meets the independence requirements established in the NYSE listing
standards and by our Corporate Governance Guidelines.
A discussion of some of the Compensation Committees processes and procedures for the consideration
and determination of executive compensation is contained in Compensation Discussion and
AnalysisSetting Executive Compensation. Additional processes and procedures include the
following:
|
|
Meetings. The Compensation Committee generally meets five times each year, with additional
meetings being scheduled as needed. The annual committee calendar is established prior to the
beginning of each year, and agendas for each meeting are established in consultation with the
Compensation Committee Chairperson. The Compensation Committee meets in executive session
during or prior to the end of each regularly scheduled meeting. |
|
|
|
Role of Consultant. During the second half of 2007, the Committee had retained Mercer LLC
as its consultant to assist the Committee in its evaluation of executive and director
compensation for 2008. After the individual consultant from Mercer who was working with the
Committee left Mercer to join Semler Brossy Consulting Group LLC, the Committee retained the
services of Semler Brossy to assist the Compensation Committee in its deliberations regarding
executive and director compensation. Specifically, the Compensation Committees consultants
provide the Committee with information relating to competitiveness of pay levels, compensation
design, market trends and technical considerations concerning both executives and directors
and assist the Compensation Committee with the reporting of executive compensation under the
SECs proxy disclosure rules. These services, which are provided in support of
decision-making by the Compensation Committee, are the only formal services that the
compensation consultant performs for Safeguard. From time to time since its hire, Semler
Brossy has provided miscellaneous data and research to the Compensation Committee relating to
various compensation topics generally. The consultant reports to and acts at the direction of,
and attends selected meetings as requested by, the Chairperson of the Compensation Committee.
The Compensation Committee has the sole authority to hire and terminate consultants and
evaluates the performance of its consultant(s) annually. |
5
|
|
Role of Executive Team. Our Chief Executive Officer, Chief Financial Officer and General
Counsel, with the assistance of other company employees as they request, provide support to
the Compensation Committee by preparing materials to assist the Committee in making its
compensation decisions; conferring with the Committee and its consultant on the selection of
peer companies and industries used for comparison purposes; providing suggestions to the
Committee in the area of executive compensation, including suggestions in the context of terms
of employment agreements, performance measures and targets under our management incentive
plan, and equity awards; and ultimately implementing the Committees compensation decisions.
Management also provides the Compensation Committee with comprehensive tally sheets on an
annual basis to facilitate the Committees review of the total compensation of our named
executive officers. The tally sheets include both historical data and estimated forward
looking amounts for the current calendar year. The tally sheets summarize: cash compensation
(salary, actual/target cash incentive awards and perquisites); the dollar value of benefits
provided; potential severance amounts payable under various scenarios; and outstanding equity
awards held by each named executive officer. The Compensation Committee discusses its
compensation views with the Chief Executive Officer, and the Chief Executive Officer makes
recommendations to the Compensation Committee for salary adjustments and equity and non-equity
plan participation and awards to the named executive officers and other executives. However,
other than for compensation that has been established contractually or under quantitative
formulas established by the Compensation Committee each year under our management incentive
plan, the Compensation Committee exercises its own discretion in determining additional
compensation, which may take the form of cash or equity, for the named executive officers and
other executives. Additional information can be found in Compensation Discussion and
AnalysisRole of Executive Team in Compensation Decisions. |
Nominating & Corporate Governance Committee. The Nominating & Corporate Governance Committees
responsibilities, which are described in detail in its charter, include, among other duties, the
responsibility to:
|
|
Establish criteria for the selection of directors; |
|
|
|
Evaluate and consider qualified Board candidates, including those recommended by
shareholders; |
|
|
|
Recommend to the Board the nominees for director, including nominees for director in
connection with Safeguards annual meeting of shareholders; |
|
|
|
Conduct an annual evaluation of the Board and its members and oversee the evaluations of
each of the Board committees; |
|
|
|
Take a leadership role in shaping Safeguards corporate governance policies, including
developing and recommending to the Board Safeguards Corporate Governance Guidelines and Code
of Business Conduct and Ethics; |
|
|
|
Evaluate the performance of the Chief Executive Officer; and |
|
|
|
Monitor the process of succession planning for the Chief Executive Officer and executive
management. |
The Nominating & Corporate Governance Committee Charter is available through the Corporate
Governance link on our website at www.safeguard.com/governance. The Board has determined that each
member of the committee meets the independence requirements established in the NYSE listing
standards and by our Corporate Governance Guidelines.
The Nominating & Corporate Governance Committee considers properly submitted shareholder
recommendations of director candidates in substantially the same manner as it considers director
candidate recommendations from other sources. Any shareholder recommendation must include the
following: the nominees name and the information about the nominee that would be required in a
proxy statement under the SECs rules; information about the relationship between the nominee and
the nominating shareholder; proof of the number of shares of Safeguard common stock that the
nominating shareholder owns and the length of time the shares of Safeguard common stock have been
owned; and a letter from the nominee certifying his or her willingness to serve, if elected, as a
director.
6
Strategy Committee. The Strategy Committee works with Safeguard management to maintain a
cooperative, interactive strategic planning process, including the identification and setting of
strategic goals and expectations. The Committee also assists management in the evaluation of
strategic alternatives and initiatives.
Item 11. Executive Compensation
COMPENSATION DISCUSSION AND ANALYSIS
Overview
The Compensation Committee (for purposes of this analysis, the Committee) is responsible for
establishing our company-wide compensation philosophy; for determining the compensation provided to
the individuals who serve as our Chief Executive Officer, Chief Financial Officer and the other
individuals included in the Summary Compensation Table (collectively referred to as the named
executive officers); and for approving the compensation for our other executives, based on
recommendations of our named executive officers. As of the date hereof, for purposes of this
analysis our executive group is comprised of a total of 11 persons, including the named executive
officers as well as six other company employees who each hold the title of vice president. The
Committee reviews our compensation philosophy each year to ensure that its principles and
objectives are aligned to our overall business strategy and aligned with the interests of our
shareholders in increasing the value of our common stock over the long term. We seek to apply a
consistent philosophy across our executive rank, not just among our named executive officers.
Compensation Philosophy and Objectives
Our overall goals in compensating our executives are to:
|
|
Attract, retain and motivate executives who are particularly qualified, as a result of
their prior professional experience, to shape Safeguards business model and pursue our
business plan, and whose experience and skills can be leveraged across our partner companies
to facilitate the partner companies growth and success; |
|
|
|
Promote and reward the achievement of short-term and long-term corporate and individual
objectives that our Board and management believe will lead to long-term growth in shareholder
value; and |
|
|
|
Encourage meaningful equity ownership and the alignment of executive and shareholder
interests as an incentive to increase shareholder value. |
The executive compensation program the Committee has created is intended to: provide an appropriate
mix of fixed and variable, at-risk cash compensation; balance rewards for short-term performance
with our ultimate goal of producing long-term shareholder value; link variable compensation as
directly as possible to value creation; and facilitate executive recruitment and retention. There
is no pre-established target for the allocation between either cash or non-cash; short-term or
long-term compensation; and/or fixed or variable items of compensation. Rather, the Committee
reviews information provided by its consultant (as well as information which may be provided by
management) to determine the appropriate level, both on an absolute and a relative basis, and mix
of each of these components.
During 2008, we used the following principal elements of compensation to meet our overall goals:
7
|
|
|
|
|
Base Pay
|
|
à
|
|
Fixed compensation, based
on competitive market
practice and existing
salary levels, that
rewards an executives
core competencies relative
to his skills,
experience, responsibility
and anticipated
contributions to us and
our partner companies; |
|
|
|
|
|
Annual Cash Incentives
|
|
à
|
|
Variable, at-risk,
performance-based
incentive compensation,
based on competitive
market practice and
existing incentive
compensation levels, that
rewards an executives
contributions towards the
achievement of short-term
corporate objectives and
achievement of individual
performance objectives; |
|
|
|
|
|
Long-Term Incentives
|
|
à
|
|
Equity awards that
encourage executive
ownership of our stock and
promote continued
employment with us during
the long-term vesting
period, thereby aligning
our executives interests
with those of our
shareholders regarding
increases in shareholder
value through improvement
in our stock price over
the long-term; |
|
|
|
|
|
Health and Welfare Benefits
|
|
à
|
|
Benefits that are part of
our broad-based employee
benefit programs,
including medical, dental,
life insurance, and
disability plans, our
401(k) plan and our
nonqualified deferred
compensation plan
(contributions to which
have been discontinued for
2009 and beyond); |
|
|
|
|
|
Perquisites
|
|
à
|
|
Limited additional
benefits that are
available to certain of
our executives; and |
|
|
|
|
|
Severance and Change-in-Control
Arrangements
|
|
à
|
|
Severance benefits that
are payable in the event a
termination of employment
occurs without cause or
for good reason. These
committed benefits are
intended to help us retain
our named executive
officers and certain of
our other executives,
providing us with
continuity of executive
management in the event
of an actual or threatened
change in control. |
Role of Named Executive Officers in Compensation Decisions
The Committee makes or has final approval authority regarding all compensation decisions with
respect to our executives. Within the parameters approved by the Committee each year, our named
executive officers are responsible for evaluating and setting compensation with respect to our
other employees.
Our Chief Executive Officer, Chief Financial Officer and General Counsel, each a named executive
officer, with the assistance of other company employees, provide support to the Committee by
preparing materials to assist the Committee in making its compensation decisions; conferring with
the Committee and its consultant on the selection of peer companies and industries used for
comparison purposes; providing suggestions to the Committee in the area of executive compensation,
including suggestions in the context of terms of employment agreements, performance measures and
targets under our management incentive plan, and equity awards; suggesting or recommending
alternative approaches to certain elements of our executive compensation philosophy; and,
ultimately, implementing the Committees compensation decisions. Management also provides the
Committee with comprehensive tally sheets on an annual basis to facilitate the Committees review
of the total compensation of our named executive officers. The tally sheets include both
historical data and estimated forward looking amounts for the current calendar year. The tally
sheets summarize: cash compensation (salary, actual/target cash incentive awards and perquisites);
the dollar value of benefits provided; potential severance amounts payable under various scenarios;
and outstanding equity awards held by each executive.
In determining the compensation of our Chief Executive Officer, the Committee considers the results
of the performance assessment conducted each year by our Nominating & Corporate Governance
Committee, which includes our Chief Executive Officers self-assessment of achievement of his
individual prior year objectives and the assessment of his performance by each Board member. The
Committee also discusses its compensation views with our Chief Executive Officer directly. Our Chief Executive Officer is not present when the
Committee makes its determinations concerning his compensation.
8
Our Chief Executive Officer annually assesses each other named executive officers performance and
makes a recommendation to the Committee concerning achievement of individual objectives. Our other
named executive officers annually assess the other executives who report to them and make
recommendations to our Chief Executive Officer concerning the achievement of individual objectives
by such executives. Our Chief Executive Officer makes recommendations to the Committee concerning
salary adjustments and equity grants to the named executive officers and, based on the
recommendations of our other named executive officers, our other executives. In determining the
compensation of our executives, the Committee considers our Chief Executive Officers assessment
and recommendations. However, other than for compensation that has been established contractually
or under quantitative formulas established by the Committee each year under our management
incentive plan, the Committee exercises its own discretion in determining whether to accept or
modify our Chief Executive Officers recommendations. These individuals are not present when the
Committee and our Chief Executive Officer review their performance or when the Committee makes its
determinations concerning their compensation.
From time to time during the year, our Chief Executive Officer may recommend to the Committee
one-time cash bonuses or stock option or other equity grants to certain executives or other
employees relating to instances of superior performance. The Committee acts on such
recommendations on a case-by-case basis.
Role of Consultant
Semler Brossy Consulting Group, LLC assisted the Committee in its deliberations regarding executive
and director compensation matters during 2008. Specifically, Semler Brossy provided information
relating to competitiveness of pay levels, compensation design, specific equity grant matters,
market trends and technical considerations, concerning both named executive officers and directors.
Semler Brossy also assisted the Committee with the reporting of executive compensation matters
relating to 2008 under applicable SEC disclosure rules. These services, which were provided in
support of decision-making by the Committee, are the only services that Semler Brossy performed for
Safeguard. Semler Brossy reported to and acted at the direction of, and attended selected meetings
as requested by, the Chairperson of the Committee.
The Committee, which has the sole authority to hire and terminate its consultant, evaluates the
performance of its consultant annually. The Committee had initially retained Mercer LLC as its
consultant during the second half of 2007 to assist the Committee in its evaluation of executive
and director compensation for 2008. After the individual consultant from Mercer who was working
with the Committee left Mercer to join Semler Brossy, the Committee decided to retain Semler Brossy
so as to be able to continue working with the individual consultant.
Setting Executive Compensation
The Committee believes that a significant portion of each executives total compensation should be
variable or at-risk. It is the view of the Committee that the greater the ability of an
executive (based on his role and responsibilities at the Company) to impact the Companys
achievement of its short- and long-term objectives, the greater the percentage of such executives
overall compensation which should be at-risk. The Committee principally utilizes variable/at-risk
cash and equity compensation (under a programmatic plan) to accomplish its objectives in this
regard. As described below under 2008 Compensation Program Cash Incentives, the Committee
provides at-risk target bonus levels under the Companys MIP (as defined below) to the Companys
executives. Payments against such targets are determined by the Committee based on both corporate
achievement as well as personal achievement. Payments may be made in cash and/or equity, in the
Committees discretion. Neither the actual awards to be made under the MIP or otherwise nor the
minimum long-term value of any equity grants made is guaranteed.
As described above, management provides the Committee with comprehensive tally sheets on an annual
basis to facilitate the Committees review of the total compensation of our named executive
officers. The Committee has found these tally sheets to be useful in its evaluation of the total
compensation program for our named executive officers. From time to time, the Committee requests
supplemental information be included in such tally sheets as its discussions require.
9
Specifically with regard to our named executive officers, the Committee from time to time, and at
least annually, has reviewed a comparison of each element of total compensation against a group of
specific companies and industries against which we believe we compete for talent and for
shareholder investment, including the venture capital and private equity industries, as well as by
reference to industry-specific compensation surveys. The analysis provided by Mercer in December
2007 for purposes of the Committees consideration of 2008 cash and total compensation levels
measured our compensation against data from the following sources:
|
|
|
|
|
Proxy Peer Group
Data
|
|
à
|
|
Business development companies, registered investment
companies and holding companies that are representative of
the unique nature of our business model for a publicly
owned company. Included in this group were: Allied
Capital Corporation; American Capital Strategies, Ltd.;
Ares Capital Corp.; Blackrock Kelso Capital; Capital
Southwest Corporation; Harris & Harris Group, Inc.;
Hercules Technology Growth Capital, Inc.; Internet Capital
Group, Inc.; MCG Capital Corporation; MVC Capital, Inc.;
NGP Capital Resources; Patriot Capital Funding; Prospect
Capital; and Technology Investment Capital Corp. |
|
|
|
|
|
Corporate
Venturing and Venture Capital
|
|
à
|
|
Surveys used included the following: |
Survey Data
|
|
|
|
2007 Mercer AERD Survey |
|
|
|
|
|
2007/2008 Watson Wyatt Report on Top Management Compensation |
|
|
|
|
|
2007 The Private Equity Analyst Holt Compensation Study |
The Committee annually evaluates the companies and surveys used for comparison purposes to be
certain that the comparables reviewed by the Committee remain appropriate. In connection with its
2008 compensation review, the Committee determined that reviewing compensation from multiple
perspectives was still appropriate given Safeguards unique business model. The Committee felt
that the analysis could be improved by refining the comparables utilized. In particular, the
Committee eliminated the comparisons to operating companies that were representative of peers to
certain of Safeguards partner companies and limited the industry classifications and asset size
parameters of companies used as proxy comparables.
Prior to 2006, we historically targeted base pay levels generally at or near the 50th
percentile of base salaries for executives having comparable duties and responsibilities to our
named executive officers. Total compensation, including both annual cash incentives and long-term
incentives, was targeted historically to fall at or near the 75th percentile of total
compensation for executives having substantially comparable duties and responsibilities to our
named executive officers, assuming achievement of Safeguards corporate, and officers individual,
objectives. However, recognizing that our business strategy, industry focus and diverse array of
partner companies make comparisons to other companies difficult, and based on the inherent
challenge in matching companies, job positions and skill sets, the Committee has viewed some of
these comparisons as more appropriate for some positions than for others and has looked to this
data for general guidance rather than rigid adherence to specific percentages. The Committee
continues to review compensation in comparison to the historically targeted 50th and
75th percentiles for base pay and total compensation, respectively, but has determined
that the overall objectives of our compensation philosophy would be better achieved through
flexibility in determining pay levels to address differences in duties and responsibilities,
individual experience, skill levels and achievements, and any retention concerns.
2008 Compensation Program
Base Pay. Base pay is established initially on the basis of several factors, including market
competitiveness; past practice; individual performance and experience; the level of responsibility
assumed; the level of skills and experience that can be leveraged across our partner companies to
facilitate their growth and success; and individual employment negotiations with newly hired
executives. Each of our named executive officers has an employment agreement with us which sets a
minimum base salary. The Committee acknowledges, in particular, that as named executive officers
leave Safeguard and new officers are hired, candidates for hire typically will review publicly
available information regarding our existing compensation levels and will condition their interest
in working for
Safeguard upon receiving compensation comparable to that of the officer they are replacing and of
other executives of Safeguard. This situation would impact the Committees ability to measurably
reduce overall compensation levels for any new senior executives, if any such reductions were
deemed appropriate by the Committee.
10
Base salaries typically are reviewed annually (at the end of one year and the beginning of the
upcoming calendar year) by the Committee, as well as in connection with a promotion or other
changes in job responsibilities. As noted above, Safeguard competes for executive talent with
venture capital and private equity firms. In considering whether to adjust base salary levels of
any of our executives for 2008, the Committee took into account:
|
|
The proxy peer group and survey data provided by Mercer; |
|
|
|
The Committees assessment of the Companys overall performance during 2007 and the
individual performance of each of our named executive officers; and |
|
|
|
United States economic conditions, in general. |
Based
on the Committees review of the foregoing, the Committee determined that base salary levels
for our then named executive officers satisfied the Committees stated objectives for the role of
fixed cash compensation within our overall compensation philosophy and made no changes to such base
salary levels for 2008, despite the fact that the Committee approved an aggregate 4% budgetary
increase in salary levels for all other of the Company employees, including other executives.
In May 2008, John Loftus, who was at the time the Companys Executive Vice President Technology,
resigned. Following Mr. Loftus departure, Kevin Kemmerer, the Companys Senior Vice President
Technology, assumed Mr. Loftus responsibilities and become a named executive officer of the
Company. Mr. Kemmerer was subsequently promoted to Executive Vice President and Managing Director,
Technology. In connection with his change in responsibilities and promotion, the Committee, based
upon our CEOs recommendation and upon the Committees review of the information provided by the
Committees consultant, raised Mr. Kemmerers annual base salary rate to $325,000 from $275,000
during 2008 and to $357,500 effective January 1, 2009.
During 2008, the Committee also approved the employment agreement which established the
compensation terms for the Companys current Chief Financial Officer, Stephen Zarrilli, who joined
the Company following the departure of Raymond J. Land. Mr Zarrilli joined us as Senior Vice
President and Chief Financial Officer in June 2008 at an initial base salary of $340,000. Mr.
Zarrillis base salary was determined based on the Committees review of Mr. Zarrillis experience
and capabilities and with reference to the salary that was paid to his predecessor as our Chief
Financial Officer, adjusted to reflect the elimination of certain executive perquisites that Mr.
Land had been receiving.
During late 2008, the Committee undertook its annual review of executive compensation. Based upon
the recommendation of the named executive officers, and on the Committees review of information
provided by Semler Brossy, as well as the Companys financial performance and the general status of
the United States economy, the Committee determined that base salary levels for our current named
executive officers satisfied the Committees stated objectives for the role of fixed cash
compensation within our overall compensation philosophy and made no changes to such base salary
levels for 2009. Based upon the recommendation of our CEO, the Committee did grant nominal base
salary increases to certain of our other executives in recognition of their professional growth and
accomplishments and additional responsibilities assumed by them.
Cash Incentives.
Incentive Opportunity. In April 2008, the Committee adopted the Companys Management Incentive
Plan (the MIP) and the particular corporate and personal objectives and target award levels for
2008 to provide a variable incentive to each of our executives and other employees based on 2008
performance. The 2008 MIP program, which emphasized teamwork among members of management to
achieve key business objectives under our 2008 strategic plan, was based on the following mix of
corporate and individual objectives for our executives:
|
|
80% on the achievement of corporate objectives; and |
|
|
|
20% on the achievement of individual objectives. |
11
Our remaining employees also participated in our 2008 MIP, with professional staff incentives being
based on the same mix of corporate and individual objectives as our executives and administrative
employee incentives being based 50% on corporate objectives and 50% on individual objectives.
We believe that short-term compensation (such as base salary and annual cash incentive awards)
should not be based on the short-term performance of our stock, whether favorable or unfavorable,
but rather on our executives management of the Company towards achieving our goal of long-term
growth in shareholder value. We also believe that under our MIP, all of our executives should earn
their incentive payments based on the same relative weighting of corporate and individual
objectives. The price of our stock should, in the long term, reflect our performance, and the
performance of our stock will directly affect the value of stock options and other equity incentive
awards provided to our executives as part of our compensation program.
Performance Measures. To align the 2008 MIP with our 2008 business strategy, the Committee
established the following corporate objectives and weightings (representing 80% (or up to 80
points) of the total 2008 MIP target award):
|
|
|
Weighting |
|
Corporate Objectives |
20%
|
|
Achievement of specified levels of deployment of capital in new partner companies; and/or
funding to support growth through acquisitions or other strategic opportunities (but
excluding working capital funding) for existing partner companies, with achievement being
measured based on the Committees view of the value of results achieved relative to the
amount of capital deployed and the number of transactions
completed; |
|
|
|
10%
|
|
Achievement of capital generation through exit transactions and/or progress towards such
exit transactions, with achievement being determined in the Committees discretion based
on its estimation of value created; |
|
|
|
30%
|
|
Achievement of explicit milestones or specified levels of revenues or profitability for
the 14 partner companies in which we held an interest as of the adoption of the 2008 MIP
(assuming the consummation of certain then-pending exit transactions), with each measure
selected to reflect the respective partner companys stage of growth and with greater
emphasis being placed on those companies in which we exercise a greater level of influence
and control based on our ownership interest, board representation, etc. and with the
Committee retaining the ability, in its discretion, to assign value to milestones
achieved, etc.; and |
|
|
|
40%
|
|
Overall
corporate performance of Safeguard, based on the Committees
subjective evaluation. |
The Committee established these objectives by taking into consideration the sales of certain
Company partner companies which were pending as of the adoption of the 2008 MIP; the stage of
development of each of the Companys remaining partner companies; the anticipated relative levels
of focus to be applied by management against the various aspects of the Companys business model
during the 2008 fiscal year; and the anticipated level of difficulty in achieving our 2008 business
plan. The Committee also wished to increase (relative to prior years) the level of discretion
which it reserved to itself in reaching final determinations of achievement levels reached. At
least in part, this desire arose from the Committees realization that, as circumstances change
throughout a given fiscal year, specific formulas or guidelines for measuring achievement set in
the beginning of a year, if strictly applied, may well prove to result in compensation grants that
do not match actual shareholder value creation. The award criteria were designed to provide
management with a meaningful guideline for meeting the Committees criteria for a target award but
not guarantee achievement or make achievement somewhat inevitable. This approach is also intended
to provide the possibility of exceeding target awards and some economic recognition, albeit
reduced, for near achievement of the target.
In connection with the finalization of the 2008 MIP, each executive also prepared written
individual objectives. Our Chief Executive Officers individual objectives were reviewed and
approved by the Committee. Each other named executive officers individual objectives were reviewed
and approved by our Chief Executive Officer, and each other executives individual objectives were
reviewed and approved by one of our named executive officers. The individual objectives varied
depending upon each participants roles and responsibilities.
12
Consistent with their respective employment agreements and the Companys overall compensation
philosophy, the Committee set the following variable target awards for 2008 for our then eligible
named executive officers:
|
|
|
|
|
|
|
Target Variable |
|
Name (1) |
|
Incentive (2) |
|
Peter J. Boni |
|
$ |
650,000 |
|
James A. Datin |
|
$ |
390,000 |
|
John A. Loftus (3) |
|
$ |
390,000 |
|
Brian J. Sisko |
|
$ |
250,000 |
|
Raymond J. Land (3) |
|
$ |
195,000 |
|
|
|
|
(1) |
|
Mr. Kemmerer was not a named executive officer at the beginning of 2008. Mr. Kemmerers
target variable incentive for 2008 was set at $309,583, after adjusting for Mr. Kemmerers
promotion in September 2008 and the related increases in his compensation, both variable and
fixed. |
|
(2) |
|
Payments under the 2008 MIP were payable in cash and/or equity. |
|
(3) |
|
Neither Mr. Loftus nor Mr. Land were employees of the Company as of year-end 2008 and,
therefore, were not eligible for any payment under the 2008 MIP. |
Under the terms of his employment agreement with us, entered into during the 2008 calendar year,
Mr. Zarrilli was initially eligible for a target MIP bonus of $195,000, beginning in 2009. In lieu
of any actual participation in our 2008 MIP, Mr. Zarrilli received, upon commencement of
employment, a payment equal to 100% of the pro rata portion of his variable cash target bonus
($113,750) based upon hire date and his initial target bonus. Mr. Zarrillis target MIP award for
2009 was raised in December 2008 by the Committee to $250,000, based on the recommendation of our
Chief Executive Officer and the Committees review of information provided by its consultant and
Mr. Zarrillis variable, at-risk compensation relative to other named executive officers.
There were no mandatory minimum awards payable under the 2008 MIP. The actual incentive awards
paid to participants were determined based upon the level of achievement of the quantitative and
qualitative corporate and individual performance objectives and were measured in the aggregate on a
sliding scale basis (e.g., for executives and professional staff, achievement of objectives
totaling 50 points would result in payment of 50% of the target award, achievement of objectives
totaling 100 points would result in payment of 100% of the target award and achievement of
objectives totaling 150 points would result in payment of 150% of the target award). Payments
under the 2008 MIP were limited to 150% of each individuals target award.
Payouts. Under the terms of our 2008 MIP, the Committee had the ability to make payments to
participants in cash and/or equity. There was no requirement that any particular portion of any
payments made be made in any particular form. In early 2009, the Committee reviewed our performance
against the quantitative and qualitative corporate objectives set forth above and preliminarily
determined the following payout levels, subject to completion of the audits of our 2008 financial
statements and internal controls over financial reporting, which completion occurred on March 19,
2009.
13
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive |
|
Payout |
|
|
|
|
Target |
|
Level |
|
|
Corporate Objectives |
|
(in points) |
|
(in points) |
|
Factors Affecting Determination |
Capital Deployment
|
|
|
16 |
|
|
|
6 |
|
|
Deployment of $15.8 million of newly committed capital in
four transactions all relating to acquisitions of new
partner company interests (Swaptree, Molecular
Biometrics, Tengion and Garnett Biotherapeutics); no
credit was given for follow-on funding to existing
partner companies. The Committee also took into
consideration the conscious effort of management to
temper the levels of cash deployment as the fiscal year
progressed and as available cash was utilized to
repurchase a portion of the Companys debt. |
|
|
|
|
|
|
|
|
|
|
|
Monetization
|
|
|
8 |
|
|
|
6 |
|
|
Accomplishment of the bundled sale of interests in five
of our legacy partner companies in a difficult secondary
market transaction in a challenging economic environment,
albeit at a price less than originally anticipated. |
|
|
|
|
|
|
|
|
|
|
|
Partner Company Performance
|
|
|
24 |
|
|
|
12 |
|
|
Achievement by
approximately 64 percent of our
partner companies of explicit milestones or minimum
specified levels of revenue or profitability. Particular
note was made of significant positive developments at two
of our largest partner companies, but also acknowledged
was the slower than targeted development of certain other
partner companies. |
|
|
|
|
|
|
|
|
|
|
|
Overall Corporate Performance
|
|
|
32 |
|
|
|
16 |
|
|
Overall corporate performance, including execution of our
business strategy; exploration of alternate sources of
funding/capital structures; restructuring of the
Companys commercial debt; opportunistic repurchase of
outstanding convertible debt of the Company; deal
sourcing and pipeline development; organizational
staffing and development; facilitating partner company
milestone achievements; building value in our partner
companies through strategy, management and performance;
and management of core corporate functions, including
performance of our investor relations and marketing
programs, financial reporting and other compliance
responsibilities, and management of our corporate
operating budget. A dominant factor in the Committees
analysis was the poor performance of the Companys stock
price throughout the year. The Committee specifically
noted the following significant 2008 achievements in its
review: |
|
|
|
|
|
|
|
|
|
|
|
Operational cost savings achieved; |
|
|
|
|
|
|
|
|
|
|
|
Progress towards commercial debt restructure
(accomplished in early 2009); |
|
|
|
|
|
|
|
|
|
|
|
The restructuring of the Companys D&O coverage
at a significant cost savings; and |
|
|
|
|
|
|
|
|
|
|
|
The market repurchase of $43 million of debt at a
significant discount to market. |
|
|
|
|
|
|
|
|
|
|
|
Total Points
|
|
|
80 |
|
|
|
40 |
|
|
(which equates to 50% achievement of corporate objectives) |
At the end of the year, each executive also completed a self-assessment of his achievement of
individual objectives (representing 20% (or up to 20 points) of the total 2008 MIP target award).
The Chief Executive Officers self-assessment was a component of the annual performance review
conducted by the Nominating & Corporate Governance Committee. The Committee reviewed with the
Nominating & Corporate Governance Committee its assessment of the performance of the Chief
Executive Officer, including his achievement of individual objectives, and discussed with the Chief
Executive Officer his review of each other named executive officers achievement of each officers
specific individual objectives.
Based on its review of the achievement of both quantitative and qualitative 2008 MIP objectives,
the Committee (i) authorized the following individual awards to the Companys named executive
officers and, in the aggregate, the following award to the Companys 10 eligible executives as a
group. In making its determinations regarding whether and in what proportions the Committee would
authorize payments to be made to our executives under the 2008 MIP, the Committee considered the
recommendation of our named executive officers that a portion of such payments be made in the form
of restricted stock of the Company. This recommendation was made by our named executive officers
in light of the Companys efforts to conserve cash resources in the current economic climate and to
demonstrate managements commitment to the Companys efforts to increase shareholder value. The
Committee determined, based also on consultations with the Committees independent consultant and
14
analysis
of data related to target incentive payment practices being followed within the Companys peer group and throughout
the United States public marketplace, as a whole, to pay (1) 50% of 2008 MIP payments to our named
executive officers, and (2) 75% of 2008 MIP payments to our other executives in cash and to pay the
remainder in the form of restricted stock. The Committee determined that paying a lower percentage
of the total award in cash to the named executive officers appropriately reflects their
line-of-sight to the overall results and the greater percentage of total executive compensation
that should be variable in nature (and linked to shareholder value).
Based on the recommendation of the named executive officers, the Committee approved the payment of
25% of 2008 MIP payments to our other executives in the form of restricted stock. It was the view
of the Committee that the payment of 50% of our named executive officers 2008 MIP payment in the
form of restricted stock versus the 25% figure utilized for our other executives appropriately
reflects the greater percentage of total executive compensation that should be variable in nature
(and linked to shareholder value created) for the senior-most executives at the Company. For
purposes of determining the specific number of shares of restricted stock to be issued to each
executive, the Committee decided that it would be appropriate to use a trailing 30-day average of
the Companys closing stock price as of February 9, 2009 ($0.664), the day of the Committees
decision to pay a portion of the 2008 MIP payments in the form of restricted stock (the principal
shares). In recognition of the deferral of a portion of this years earned award, the Committee
also determined that, in addition to each principal share of restricted stock to be issued,
calculated as described above, an additional .44163 shares of restricted stock would be issued.
Initially, the Committee had desired to issue an additional .5 shares for each principal share, but
they determined to limit the number of additional shares issued to our named executive officers to
the number of shares available under the Companys 1999 Equity Compensation Plan, as opposed to
also utilizing shares available under the Companys 2004 Equity Compensation Plan. Assuming the
continued employment of the particular executive as of such dates, the restricted shares issued
vest as follows: 25% on the first anniversary of grant and the remaining 75% thereafter in 24 equal
monthly installments over the next two years. Vesting of such restricted stock may be accelerated
in certain circumstances. The issuance of additional shares of restricted stock beyond the
principal shares in the 2008 MIP payments does not establish a policy or precedent going forward.
The Committee will view each year independently.
The cash amounts pertaining to our named executive officers are also presented in the Summary
Compensation Table under Non-Equity Incentive Plan Compensation. The cash portions of such
amounts were paid following the completion of the audit of our financial statements. The
restricted shares were issued in 2009 and will be reported in next years proxy statement.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Variable |
|
|
|
|
|
|
|
|
|
Payout |
|
|
Incentive |
|
|
Total Cash |
|
|
Restricted |
|
Name |
|
Level (1) |
|
|
Payment |
|
|
Amount (2) |
|
|
Shares (3) |
|
Peter J. Boni |
|
|
56 |
|
|
$ |
364,000 |
|
|
$ |
182,000 |
|
|
|
395,144 |
|
James A. Datin |
|
|
58 |
|
|
$ |
226,200 |
|
|
$ |
113,100 |
|
|
|
245,554 |
|
Kevin L. Kemmerer |
|
|
56 |
|
|
$ |
173,366 |
|
|
$ |
86,683 |
|
|
|
188,200 |
|
Brian J. Sisko |
|
|
60 |
|
|
$ |
150,000 |
|
|
$ |
75,000 |
|
|
|
162,834 |
|
Eligible
executives, as a
group (10
persons)(4) |
|
|
58 |
|
|
$ |
1,263,647 |
|
|
$ |
719,343 |
|
|
|
1,181,751 |
|
|
|
|
(1) |
|
In percentage terms versus targeted incentive amount. |
|
(2) |
|
50% of total payment for named executive officers; 75% of total payment for other
executives. |
|
(3) |
|
Issued in lieu of cash for remaining portion of total payment. Includes principal shares
as well as additional shares issued as described above. |
|
(4) |
|
Mr. Zarrilli is one of our named executive officers and our executive group, but he was not
eligible for our 2008 MIP based on the terms of his employment agreement with the Company. |
By way of comparison, after taking into consideration the achievement of both corporate and
individual objectives, payments to our then named executive officers were made at approximately 70%
of target under our 2007 MIP; a range of 102% to 114% of target under our 2006 MIP; and a range of
88.5% to 130% of target under our 2005 MIP.
15
The Committee has not made any determination as to the ways in which payments under our 2009 MIP
will be made. The Committee is aware that, under our presently existing shareholder-approved
equity compensation plans, there is little, if any, availability of shares available for issuance
to our named executive officers. The Committee is currently reviewing various alternatives with
respect to the availability of shares. But, unless our shareholders approve an addition to our
current equity compensation plans, it is extremely unlikely that the Committee will be able to
utilize restricted stock as part of any 2009 MIP payments.
Long-Term Incentives. The principal approach utilized by the Committee to meet the need for a
long-term incentive component to the Companys executive compensation program has been the granting
of significant amounts of equity to our named executive officers, primarily in the form of stock
options. Our equity compensation plans also allow for the grant of restricted stock awards and
such other equity-based awards as the Committee may determine to be appropriate from time to time.
As described above under 2008 Compensation Program Cash Incentives Payouts, the Committee chose
to pay a significant portion of 2008 MIP awards in the form of restricted stock with a three-year
vesting schedule.
As noted above, we compete for executive talent with venture capital and private equity firms, and
we review comparative information regarding venture capital and private equity industry
compensation practices. In such industries, executives (referred to as managing partners)
typically have compensation programs heavily weighted towards long-term incentive, structured as a
share of the funds profits, payable in cash (referred to as carry). We currently do not provide
our executives with a cash compensation program tied directly to gains from our sales of our
partner company holdings. Instead, we have to date utilized our equity compensation plans as an
alternative to approximate the economic benefit that would be provided by a carry. The initial
equity awards made to our named executive officers were based on our assessment of the carry which
would typically be provided to our executives in positions of comparable responsibility at private
equity and/or venture capital firms at that time. For example, based upon information available to
the Committee through its consultant, as well as directly through the professional experience of
Committee members, a managing partner of a venture capital or private equity firm would typically
expect a carry ranging from about 1% to 5% of profits realized on portfolio transactions. To
provide a different, but somewhat comparable, long-term economic benefit to our named executive
officers, we granted stock options to our named executive officers, with each officers aggregate
stock option grants ranging from about 1% to 5% of our outstanding shares of common stock,
dependent upon the individuals position and responsibilities. The ultimate potential value of the
grants is intended to be competitive with those held by comparable executives in the comparison
data reviewed by the Committee (as adjusted for the senior executives experience).
The Committees deliberations with regard to long-term incentives during 2008 were made
increasingly challenging by a variety of factors the current economic environment impacted the
opportunity to realize the value of long-term incentives, and the retentive value of long-term
incentive grants made to the named executives upon hire declined precipitously through the course
of the year. In an effort to better approximate a carry approach, the Committee considered a
variety of alternatives for long-term incentives, including cash, restricted stock, and stock
options, with all of these approaches tied to gains derived by the Company from sales of our
partner company interests. The Committee decided to continue the use of options as the principal
component of its long-term incentive program, but changed the performance criteria for new grants
from the market-based approach (described below) which has been utilized since 2005, to the
capital-return approach (described below). The Committee believes this vehicle best ties the
reward to the factors critical to the creation of shareholder value.
Our stock options are granted with an exercise price equal to the average of the high and low
trading prices of our common stock on the date of grant. Therefore, the options will have value
only if the market price increases after that date and, in the case of options that vest upon
achievement of specified performance milestones, only if the specified performance milestones are
achieved. We refer to options that vest upon achievement of specified performance milestones as
performance-based options. At present, we have issued and outstanding two types of
performance-based options: market-based vesting options and capital-return options (initiated
in 2008). Both of these types of performance-based options are described in detail below.
16
In general, for executive personnel, the Committee has established the following model for
allocating option grants (both initial and any annual grants) between options which are subject to
simple time-based vesting and performance-based options:
|
|
25% of the total underlying shares are subject to time-based vesting; of such amount, 25%
vests on the first anniversary date of the grant date and the remaining 75% vests in 36 equal
monthly installments on the same date of each month thereafter; and |
|
|
|
75% of the total underlying shares are subject to performance-based vesting. |
The Committee believes that allocating option grants in such a fashion aligns the long-term
interests of Safeguard management and our shareholders. The Committee may infrequently grant
options allocated in a different manner, in special circumstances. All option grants to our named
executive officers in 2008 were allocated in the above manner.
Based in general on the circumstances created by the general market collapse in the Fall of 2008
and, in particular, the poor performance of the Companys stock price, during 2008, the Committee
also solicited advice from its consultant as well as from the Companys legal advisors regarding
the possibility of undertaking a stock option exchange initiative. Despite the fact that the large
majority of the Companys outstanding stock options have exercise prices which are significantly
above the Companys current public share price, the Committee did not deem it appropriate or
advisable to undertake any exchange at this time. The Committee continues to assess the impact on
executive and non-executive retention and incentive which the circumstances at present create.
Market-based Options. Our market-based vesting options vest as the Companys per share price on the
NYSE achieves certain specified levels in excess of the exercise price of such options. The
Committee began utilizing these market-based vesting options during 2005 and continued to utilize
them through the second quarter of 2008. Our executives will not benefit from such option grants
unless our stock price achieves and sustains a targeted stock price (based on the average closing
price of a share of our common stock as reported on the NYSE composite tape for 20 consecutive
trading days).
The following table shows the per share stock price levels at which portions of the shares
underlying the market-based vesting options granted in 2005 and 2006 to Messrs. Boni, Datin and
Kemmerer will vest:
|
|
|
|
|
Percentage of Shares Underlying Options That Vest |
|
Per Share Stock Price |
|
First 10% |
|
$ |
2.0359 |
|
Next 20% |
|
$ |
3.1548 |
|
Next 30% |
|
$ |
4.6466 |
|
Final 40% |
|
$ |
6.5114 |
|
During 2008, market-based vesting options were issued to Mr. Kemmerer in connection with his
undertaking increased responsibilities following Mr. Loftus departure. Also, upon joining
Safeguard in June 2008, Mr. Zarrilli received stock options to purchase 1,500,000 shares. Mr.
Zarrillis option grants met the employment inducement award exemption provided under Section
303A.08 of the NYSE Listed Company Manual. Of the stock options awarded to Messrs. Kemmerer and
Zarrilli, 25% of the stock options were subject to time-based vesting and 75% of the stock options
were subject to the market-based vesting model. The market-based options issued to Mr. Sisko in
2007 and to Messrs. Kemmerer and Zarrilli during 2008 will vest as follows:
|
|
|
|
|
Percentage of Shares Underlying Options That Vest |
|
Per Share Stock Price |
|
First 20% |
|
$ |
3.1548 |
|
Next 30% |
|
$ |
4.6466 |
|
Next 40% |
|
$ |
6.5114 |
|
Final 10% |
|
$ |
7.2246 |
|
Market-based options also may vest on a pro rata basis if the per share stock price is between the
designated stock price levels set forth in the above tables for 20 consecutive trading days. We
measure for these pro rata vestings every six months. For example, based on the stock price levels
in the first table above, if the first 10% of the options have already vested and within the next
six-month window, the highest average closing price of a share of our
common stock as reported on the NYSE composite tape over 20 consecutive trading days equals
$2.5954, an additional 10% of the shares underlying the options will vest.
17
Capital-Return Options. During the third quarter of 2008, based upon discussions with the
Committees consultant and in an attempt to 1) formally incorporate the granting of equity as part
of the annual total compensation package; 2) better approximate the carry concept described
above; and 3) better link compensation to two principal elements of the Companys business plan for
producing enhanced shareholder value, increasing the value of our partner company interests and
consummating exit transactions to realize such value, the Committee formulated the following
capital-return option model. The principle behind the capital-return model is to vest options as
partner company exit transactions produce aggregate cash returns to the Company in excess of
certain predetermined levels. In order to create a starting point for the use of this vesting
approach, the Committee formed a group consisting of all of the Companys partner companies
existing as of September 30, 2008, other than Clarient (The Initial Group) and tied the vesting
of the performance-based options issued on such date to predetermined levels of net cash proceeds
returned to the Company based on exit transactions involving the Initial Group. Vesting of these
options will be calculated annually as of the anniversary date of the grant. Vesting will only
begin to occur after a hurdle amount of proceeds are produced and all options will become vested
upon achievement of a predetermined target amount of proceeds. After such hurdle amount is
reached, the options will vest on a linear basis relative to additional proceeds produced beyond
the hurdle amount and the target amount until such time as 100% of the options are vested when the
target amount of proceeds is reached. Adjustments to the hurdle amount and the target amount will
be made if and when the Company deploys additional capital into any of the Initial Group. It is
contemplated that, on an annual basis going forward, on or about the anniversary date of the
formation of the Initial Group, the Committee will create an additional grouping of partner
companies defined as companies into which the Company first deployed capital during the preceding
12 months. The vesting of any stock option issuances to be made at that time (or within the
next 12 months) in the normal course of the Committees management of executive compensation equity
matters would be tied to net proceeds produced from exit transactions involving such group of
partner companies.
The Committee annually reviews the equity awards held by our executives and other employees and
also may consider awards periodically during a year in an effort to retain and motivate employees
and to ensure continuing alignment of executive and shareholder interests. Information regarding
the stock option grants made to our named executive officers during 2008 can be found below under
Executive Compensation Grants of Plan-Based Awards 2008.
Subject to availability under our shareholder approved equity compensation plans, we expect to
continue to use stock options and other equity awards as part of our executive compensation
program, including performance-based options.
Stock Option/Equity Granting Process. The Committee is responsible for equity grants under our
equity compensation plans. The Committee approves and grants all equity awards to our executives,
employees and advisory board members, with the exception of those grants for which the Committee
has delegated authority to the Chief Executive Officer which are described below. Equity grants to
directors are generally approved by the Board; however, in those cases where the Board has approved
the size and form of recurring annual service grants, the Committee may authorize grants without
further Board approval.
Grants may be made at regularly scheduled meetings or at special meetings convened to approve
compensation arrangements for newly hired executive officers or for executive officers who have
been promoted or are otherwise subject to changes in
responsibilities. During 2007, the Committee
determined that, as a matter of best practice, recurring grants to directors and advisory board
members would be made on the date of Safeguards annual meeting
of shareholders. During 2008, the Committee
further determined that it would also begin utilizing the end of the Companys fiscal third quarter
each year as an acceptable and administratively convenient time to make annual determinations
regarding executive equity compensation matters. It is presently contemplated that, at that time in
each calendar year going forward, and in connection with the process described above regarding the
Companys capital-return option model, the Committee may issue additional options (or other forms
of incentive equity) to some or all of the Companys executives. This annual process was
established in 2008 in recognition of the fact that the core of the Companys senior management
team was established beginning in 2005 and that, based on the term of the Companys option grants,
it would be appropriate to begin an annual option review and potential programmatic
supplemental grant designed to deliver an annual long-term incentive value relative to each
executives roles and responsibilities. The Committee believes that granting equity on an annual
basis will 1) provide greater alignment between the performance achieved and the value realized; 2)
reinforce equity value as an important component of each executives annual total compensation; and
3) recognize the executives ongoing role in achieving results rather than the point in time that
they joined the Company.
18
The Committee has delegated to our Chief Executive Officer the authority to make equity grants
between regularly scheduled Committee meetings (primarily to new hires and new advisory board
members), provided that the aggregate number of shares granted may not exceed 300,000 shares, the
maximum number of shares allocated to any one employee may not exceed 125,000 shares and the
aggregate number of shares allocated to any one advisory board member may not exceed 5,000 shares.
A report is made to the Committee at each of its regularly scheduled meetings regarding any grants
that our Chief Executive Officer has approved since the date of the last report, following which
the aggregate number of shares available is reset to 300,000 shares. The Chief Executive Officer
is not authorized to make equity grants to executives or directors without prior Committee approval
of the specific grant contemplated.
It recently has become our practice to make all employee grants of options, subject to limited
exceptions for new hires, on fixed quarterly grant dates. Grants to newly retained consultants or
advisors may be made on the later of the date the award is approved or the date of commencement of
services. The exercise price for all stock options granted under our equity compensation plans is
the average of the high and low trading prices of our common stock as reported on the NYSE
composite tape on the date of grant, which we believe reflects common practice.
Nonqualified Deferred Compensation. Our executives may defer compensation under our qualified
401(k) plan (subject to the limits imposed by the Internal Revenue Code) but generally, due to the
structure of our 401(k) plan, the most highly compensated of our executives (including our named
executive officers) were not eligible to receive matching company contributions under that plan for
calendar years through 2008. In lieu of such a matching 401(k) contribution, such executives were
eligible to participate in our nonqualified deferred compensation plan, which is an unfunded plan
that does not allow deferral of compensation but does allow participants to obtain credits, in the
form of Safeguard contributions allocated to accounts for the benefit of participants. We offered
this nonqualified deferred compensation plan to those executives excluded from matching
contributions in light of their ineligibility to obtain a Company matching contribution under our
qualified 401(k) plan. During 2008, the Committee approved a change to our 401(k) plan which will
allow matching contributions for all of our employees for calendar years beginning with 2009.
Therefore, no further contributions are expected to be made under our non-qualified deferred
compensation plan for calendar years beyond 2008. Amounts accrued for prior periods will continue
to be credited to prior participants in accordance with the terms of the plan. Additional
information regarding participation in this plan by named executive officers can be found below
under Executive CompensationNonqualified Deferred Compensation 2008.
Perquisites (fringe benefits). Contractually, certain of our executives are entitled to a few
benefits that are not otherwise available to our employees generally. We do not provide a defined
benefit pension arrangement, post-retirement health coverage or similar benefits for any of our
executives. During 2008, we provided universal life insurance coverage ranging from $750,000 to
$1,000,000 to each of our named executive officers. In addition, the following additional
perquisites were provided to all of our named executive officers in fiscal 2008, other than to Mr.
Zarrilli:
|
|
$10,000 annual car allowance; |
|
|
$8,000 non-accountable annual expense allowance; and |
|
|
Up to $5,000 reimbursement annually for medical, vision or dental expenses not covered
under our other benefit plans. |
The Committee believes that these perquisites, which represent a relatively modest portion of each
named executive officers compensation, are not out of the ordinary for executives of the caliber
that we needed to be able to attract to Safeguard. These perquisites are taken into consideration
by the Committee in determining total compensation payable to the named executive officers. It is
the Committees stated intention to begin to treat certain of such perquisites as fully
discretionary in the case of any new hires to our senior executive ranks.
19
Severance and Change-in-Control Arrangements
Each of our named executive officers has an agreement with Safeguard which provides certain
benefits in the event of termination of his employment by Safeguard without cause or by the
officer for good reason (as defined in the agreements). Messrs. Land and Loftus voluntarily
resigned as Safeguard employees in May 2008 and, therefore, received no severance payments.
Upon the occurrence of a termination event, each executive will be entitled to those benefits
outlined in his agreement with us, which may include a multiple of his then current base salary,
payment of his pro rata bonus for the year of termination or a multiple of the greater of his
target bonus for the year of termination or the average of his actual bonuses for up to the last
three years, accelerated vesting of equity awards and extension of the post-termination exercise
period within which some or all of the equity awards held by the executive may be exercised,
coverage under our medical, health and life insurance plans for a designated period of time, and
outplacement services or office space. See Potential Payments upon Termination or Change in
Control elsewhere herein for a summary of the specific benefits that each executive will receive
upon the occurrence of a termination event.
Unlike single trigger change-in-control arrangements that pay out immediately upon a change in
control, most of the benefits to which our named executive officers are entitled under their
agreements in the event of a change in control require a double trigger, namely a change in
control coupled with a loss of employment or a substantial change in job duties. We believe a
double trigger provides retention incentives as well as continuity of management in the event of
an actual or threatened change in control. However, we note that the acceleration of the vesting
of the stock options that have been granted to Mr. Boni require only a single trigger to be
effective that is, only a change in control. This arrangement was specifically negotiated by Mr.
Boni as a condition to his agreement to join Safeguard. Since equity represents a significant
portion of Mr. Bonis total compensation, we believe that this single trigger can be an important
retention device during changein-control discussions.
Deductibility of Executive Compensation
The Committee considers the potential impact of Section 162(m) of the Internal Revenue Code in
structuring executive compensation. Section 162(m) disallows a tax deduction for any publicly held
corporation for certain executive compensation exceeding $1,000,000 per person in any taxable year
unless it is performance based within the meaning of Section 162(m). We believe the stock
options awarded under our equity compensation plans are in compliance with the provisions of
Section 162(m). The portion of cash compensation paid to Mr. Boni for 2008 in excess of $1,000,000
was not performance-based compensation within the meaning of Section 162(m) and, therefore, was
not deductible by Safeguard. We believe that providing an appropriate level of cash compensation
and maintaining flexibility in determining compensation may be more important than preserving this
tax deduction. Therefore, the Committee does not currently plan to take any action to qualify any
of our cash incentive compensation plans under Section 162(m).
Stock Ownership Guidelines
Our Board established stock ownership guidelines, effective December 31, 2005, that are designed to
closely align the long-term interests of our named executive officers with the long-term interests
of our shareholders. The guidelines provide that each named executive officer should attain an
equity position in our common stock equal to two times annual base salary. The ownership level
should be achieved (i) within five years of December 31, 2005 for executive officers who were
employed on that date or (ii) for individuals who were not employees on December 31, 2005, by the
end of the fifth full calendar year following the year in which the executive officer was hired.
The Nominating & Corporate Governance Committee monitors compliance as of the end of each calendar
year. Shares counted toward these guidelines include:
|
|
Shares beneficially owned by the executive officer; |
|
|
Vested shares of restricted stock; |
|
|
Vested deferred stock units that have been credited to the executive officer; and |
|
|
Shares underlying vested, in-the-money options. |
20
Based on information they have provided to us, our named executive officers are working toward
meeting the guidelines within the prescribed time frames.
Prohibition on Speculation in Safeguard Stock
Our company policy on securities trading by company personnel prohibits our named executive
officers, directors and other employees from engaging in activities with regard to our stock that
can be considered as speculative, including but not limited to, short selling (profiting if the
market price of our securities decreases); buying or selling publicly traded options (e.g., a put
option, which is an option or right to sell stock at a specific price prior to a specified date, or
a call option, which is an option or right to buy stock at a specific price prior to a specified
date); and hedging or any other type of derivative arrangement that has a similar economic effect.
Our executive officers and directors also are prohibited from pledging, directly or indirectly, our
common stock or the stock of any of our partner companies, as collateral for indebtedness.
COMPENSATION COMMITTEE REPORT
We have reviewed and discussed the foregoing Compensation Discussion and Analysis with management.
Based on our review and discussion with management, we have recommended to the Board of Directors
that the Compensation Discussion and Analysis be included in the Companys Annual Report on Form
10-K and the Companys proxy statement.
Members of the Compensation Committee:
|
|
|
|
|
Julie A. Dobson, Chairperson
|
|
George D. McClelland
|
|
John J. Roberts |
21
EXECUTIVE COMPENSATION
Summary Compensation Table Fiscal Years Ended December 31, 2008, 2007 and 2006
The table below is a summary of total compensation paid to or earned by our named executive
officers for the fiscal years ended December 31, 2008, 2007 and 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity |
|
|
and |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive |
|
|
Nonqualified |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan |
|
|
Deferred |
|
|
All Other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock |
|
|
Option |
|
|
Compen- |
|
|
Compensation |
|
|
Compen- |
|
|
|
|
Name and |
|
|
|
|
|
Salary |
|
|
Bonus |
|
|
Awards |
|
|
Awards |
|
|
sation |
|
|
Earnings |
|
|
sation |
|
|
Total |
|
Principal Position |
|
Year |
|
|
($) |
|
|
($)(1) |
|
|
($)(2) |
|
|
($)(2) |
|
|
($)(3) |
|
|
($)(4) |
|
|
($)(5) |
|
|
($) |
|
Peter J. Boni |
|
|
2008 |
|
|
|
650,000 |
|
|
|
|
|
|
|
|
|
|
|
578,521 |
|
|
|
182,000 |
|
|
|
|
|
|
|
74,323 |
|
|
|
1,484,844 |
|
President and Chief |
|
|
2007 |
|
|
|
650,000 |
|
|
|
|
|
|
|
|
|
|
|
710,745 |
|
|
|
455,000 |
|
|
|
267 |
|
|
|
116,049 |
|
|
|
1,932,061 |
|
Executive Officer |
|
|
2006 |
|
|
|
600,000 |
|
|
|
|
|
|
|
|
|
|
|
1,185,249 |
|
|
|
684,000 |
|
|
|
|
|
|
|
248,935 |
|
|
|
2,718,814 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
James A. Datin |
|
|
2008 |
|
|
|
390,000 |
|
|
|
|
|
|
|
|
|
|
|
354,414 |
|
|
|
113,100 |
|
|
|
|
|
|
|
46,961 |
|
|
|
904,475 |
|
Executive Vice President |
|
|
2007 |
|
|
|
390,000 |
|
|
|
|
|
|
|
|
|
|
|
435,321 |
|
|
|
273,000 |
|
|
|
267 |
|
|
|
47,441 |
|
|
|
1,146,029 |
|
and Managing Director, |
|
|
2006 |
|
|
|
375,000 |
|
|
|
|
|
|
|
|
|
|
|
713,813 |
|
|
|
382,500 |
|
|
|
|
|
|
|
44,989 |
|
|
|
1,516,302 |
|
Life Sciences |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kevin L. Kemmerer (6) |
|
|
2008 |
|
|
|
309,337 |
|
|
|
|
|
|
|
|
|
|
|
191,722 |
|
|
|
86,683 |
|
|
|
|
|
|
|
45,081 |
|
|
|
632,823 |
|
Executive Vice President
and Managing Director,
Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brian J. Sisko |
|
|
2008 |
|
|
|
340,000 |
|
|
|
50,000 |
|
|
|
|
|
|
|
260,295 |
|
|
|
75,000 |
|
|
|
|
|
|
|
48,109 |
|
|
|
773,404 |
|
Senior Vice President and |
|
|
2007 |
|
|
|
126,410 |
|
|
|
91,096 |
|
|
|
|
|
|
|
148,345 |
|
|
|
|
|
|
|
|
|
|
|
6,238 |
|
|
|
372,089 |
|
General Counsel |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stephen T. Zarrilli (7) |
|
|
2008 |
|
|
|
198,333 |
|
|
|
113,750 |
|
|
|
|
|
|
|
123,750 |
|
|
|
|
|
|
|
|
|
|
|
14,006 |
|
|
|
449,839 |
|
Senior Vice President and |
|
|
2007 |
|
|
|
327,500 |
|
|
|
|
|
|
|
|
|
|
|
44,563 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
372,063 |
|
Chief Financial Officer |
|
|
2006 |
|
|
|
15,000 |
|
|
|
|
|
|
|
|
|
|
|
25,577 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,577 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Raymond J. Land (8) |
|
|
2008 |
|
|
|
135,417 |
|
|
|
|
|
|
|
|
|
|
|
(267,792 |
) |
|
|
|
|
|
|
|
|
|
|
21,559 |
|
|
|
(110,816 |
) |
Former Senior Vice |
|
|
2007 |
|
|
|
182,292 |
|
|
|
109,375 |
|
|
|
|
|
|
|
292,344 |
|
|
|
|
|
|
|
|
|
|
|
32,367 |
|
|
|
616,378 |
|
President and Chief
Financial Officer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
For 2008, the amount reported for Mr. Zarrilli represents an amount paid to him when he
returned to Safeguard as an employee in June 2008 in lieu of participation in our Management
Incentive Plan (MIP) for 2008. For 2007, the amounts reported for Messrs. Sisko and Land
represent amounts paid to them upon their hire in lieu of participation in our 2007 MIP. |
|
(2) |
|
These amounts do not represent compensation actually received. Rather, these amounts
represent the aggregate expense we recognized for financial statement reporting purposes for
the fiscal year ended December 31, 2008 for stock options granted during and prior to 2008, in
accordance with FAS 123(R). In accordance with SEC rules, the amounts shown exclude the
effect of estimated forfeitures related to service-based vesting conditions other than
forfeitures that actually occurred during 2008. The stock options held by Mr. Land were
forfeited, in accordance with the terms of his stock option agreements, following his termination of
employment. Therefore, under FAS 123(R), the expenses previously
reported with respect to the stock options that Mr. Land
forfeited were reversed, and, in accordance with SEC rules, the
reversal resulted in the negative amount shown in the table. The fair value of each stock
option is estimated on the date of grant using the Black-Scholes option-pricing model with the
following weighted-average assumptions for the years indicated: |
22
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008 |
|
|
2007 |
|
|
2006 |
|
|
2005 |
|
|
2004 |
|
Service-Based Awards: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend yield |
|
|
0 |
% |
|
|
0 |
% |
|
|
0 |
% |
|
|
0 |
% |
|
|
0 |
% |
Expected volatility |
|
|
52 |
% |
|
|
61 |
% |
|
|
69 |
% |
|
|
84 |
% |
|
|
86 |
% |
Average expected option life |
|
5 years |
|
|
5 years |
|
|
5 years |
|
|
5 years |
|
|
5 years |
|
Risk-free interest rate |
|
|
3.1 |
% |
|
|
4.5 |
% |
|
|
4.7 |
% |
|
|
4.4 |
% |
|
|
3.6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Market-Based Awards: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend yield |
|
|
0 |
% |
|
|
0 |
% |
|
|
0 |
% |
|
|
0 |
% |
|
|
N/A |
|
Expected volatility |
|
|
59 |
% |
|
|
55 |
% |
|
|
62 |
% |
|
|
67 |
% |
|
|
N/A |
|
Average expected option life |
|
5 7 years |
|
|
5 7 years |
|
|
5 7 years |
|
|
5 7 years |
|
|
|
N/A |
|
Risk-free interest rate |
|
|
3.4 |
% |
|
|
5.0 |
% |
|
|
4.8 |
% |
|
|
4.3 |
% |
|
|
N/A |
|
Performance-Based Awards: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend yield |
|
|
0 |
% |
|
|
N/A |
|
|
|
N/A |
|
|
|
N/A |
|
|
|
N/A |
|
Expected volatility |
|
|
50 |
% |
|
|
N/A |
|
|
|
N/A |
|
|
|
N/A |
|
|
|
N/A |
|
Average expected option life |
|
4.4 years |
|
|
|
N/A |
|
|
|
N/A |
|
|
|
N/A |
|
|
|
N/A |
|
Risk-free interest rate |
|
|
3.0 |
% |
|
|
N/A |
|
|
|
N/A |
|
|
|
N/A |
|
|
|
N/A |
|
|
|
|
|
|
For information regarding the grant date fair value of awards granted in 2008, see Grants of
Plan-Based Awards 2008 below. |
|
(3) |
|
For 2008, the amounts reported in this column represent the cash payments made in March 2009
for awards earned under our 2008 MIP. As described in detail under Compensation Discussion
and Analysis 2008 Compensation Program, the Compensation Committee determined that amounts
earned under the 2008 MIP by our named executive officers would be paid 50% in cash and 50% in
restricted stock. The restricted stock, which was issued in February 2009, will be reported
in the tables that will be included in our 2010 proxy statement. |
|
(4) |
|
For 2008, Messrs. Boni, Datin and Kemmerer realized a notional loss of $16,070, $16,070 and
$22,622, respectively, in the amounts credited to them under the Executive Deferred
Compensation Plan; these losses are reported below under Nonqualified Deferred Compensation
2008. |
|
(5) |
|
For 2008, All Other Compensation included the following amounts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonqualified |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation |
|
|
|
|
|
|
|
|
|
|
Perquisites |
|
|
Plan or 401(k) |
|
|
|
|
|
|
Group Life |
|
|
|
and Personal |
|
|
Matching |
|
|
Life Insurance |
|
|
Insurance |
|
Name |
|
Benefits |
|
|
Contribution |
|
|
Premiums |
|
|
Imputed Income |
|
Peter J. Boni |
|
$ |
23,000 |
|
|
$ |
17,250 |
|
|
$ |
30,509 |
|
|
$ |
3,564 |
|
James A. Datin |
|
|
22,169 |
|
|
|
17,250 |
|
|
|
6,930 |
|
|
|
612 |
|
Kevin L. Kemmerer |
|
|
22,881 |
|
|
|
17,250 |
|
|
|
4,640 |
|
|
|
310 |
|
Brian J. Sisko |
|
|
22,917 |
|
|
|
17,250 |
|
|
|
7,420 |
|
|
|
522 |
|
Stephen T. Zarrilli |
|
|
|
|
|
|
9,246 |
|
|
|
4,455 |
|
|
|
305 |
|
Raymond J. Land |
|
|
13,386 |
|
|
|
|
|
|
|
7,265 |
|
|
|
908 |
|
|
|
|
|
|
For Messrs. Boni, Datin, Kemmerer, Sisko and Land, the perquisites and personal benefits include
a $10,000 annual car allowance (prorated for individuals employed for less than the full year),
an $8,000 non-accountable annual expense allowance, and reimbursement of up to $5,000 annually
for medical, vision or dental expenses not covered under our other benefit plans. Our named
executive officers also have occasional personal use of tickets to various sporting events at no
incremental cost to us and are eligible to receive matching charitable contributions under our
program, which is available to all employees, subject to a maximum of $1,500 in matching
contributions for each individual for each calendar year. |
|
(6) |
|
Mr. Kemmerer became an executive officer of Safeguard in April 2008. |
|
(7) |
|
Mr. Zarrilli served, on a consulting basis, as our Acting Senior Vice President, Acting Chief
Administrative Officer and Acting Chief Financial Officer from December 2006 until mid-June
2007 and rejoined Safeguard as an employee in June 2008 as our Senior Vice President and Chief
Financial Officer. |
|
(8) |
|
Mr. Land resigned in
May 2008. See footnote 2 for an explanation of the negative
amount of total compensation reported for Mr. Land. |
23
Each of our current named executive officers has an employment agreement with us that sets his
initial base salary and initial minimum annual cash incentive target award. The initial base
salary and initial minimum annual cash incentive target award for each named executive officer
employed as of December 31, 2008, were as follows: Mr. Boni ($600,000 salary; $600,000 target
award); Mr. Datin ($375,000 salary; $375,000 target award); Mr. Kemmerer ($325,000 salary; $325,000
target award); Mr. Sisko ($340,000 salary; $250,000 target award); and Mr. Zarrilli ($340,000
salary; $195,000 target award). Base salaries and annual cash incentive target awards, which are
reviewed by the Compensation Committee each year, currently exceed these contractual minimum
amounts for Messrs. Boni, Datin and Kemmerer and Mr. Zarrillis annual cash incentive target award
currently exceeds his contractual minimum amount. The primary focus of these agreements is to
provide our executive officers with severance benefits in the event of a termination of employment
involuntarily, for good reason or upon a change in control, as described below under Potential
Payments upon Termination or Change in Control. The components of compensation reported in the
Summary Compensation Table, including an explanation of the amount of salary and cash incentive
compensation in proportion to total compensation, are described in detail under Compensation
Discussion and Analysis.
Grants of Plan-Based Awards 2008
The following table shows non-equity incentive plan awards and option awards granted during 2008 to
our named executive officers. There were no stock awards granted to our named executive officers
during 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Other |
|
|
All Other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock |
|
|
Option |
|
|
|
|
|
|
|
|
|
|
Grant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards: |
|
|
Awards: |
|
|
Exercise |
|
|
|
|
|
|
Date Fair |
|
|
|
|
|
|
|
Estimated Possible Payouts Under |
|
|
Number of |
|
|
Number of |
|
|
or Base |
|
|
|
|
|
|
Value of |
|
|
|
|
|
|
|
Non-Equity Incentive Plan Awards |
|
|
Shares of |
|
|
Securities |
|
|
Price of |
|
|
Market |
|
|
Stock and |
|
|
|
|
|
|
|
(1) |
|
|
Stock or |
|
|
Underlying |
|
|
Option |
|
|
Price on |
|
|
Option |
|
|
|
Grant |
|
|
Threshold |
|
|
Target |
|
|
Maximum |
|
|
Units |
|
|
Options |
|
|
Awards |
|
|
Grant Date |
|
|
Awards |
|
Name |
|
Date |
|
|
($) |
|
|
($) |
|
|
($) |
|
|
(#) |
|
|
(#)(2) |
|
|
($/Sh) |
|
|
($/Sh)(3) |
|
|
($)(4) |
|
Peter J. Boni |
|
|
4/22/08 |
|
|
|
|
|
|
|
650,000 |
|
|
|
975,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9/30/08 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
900,000 |
(5) |
|
|
1.235 |
|
|
|
1.25 |
|
|
|
490,090 |
|
|
|
|
9/30/08 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
300,000 |
(6) |
|
|
1.235 |
|
|
|
1.25 |
|
|
|
177,660 |
|
|
James A. Datin |
|
|
4/22/08 |
|
|
|
|
|
|
|
390,000 |
|
|
|
585,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9/30/08 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
450,000 |
(5) |
|
|
1.235 |
|
|
|
1.25 |
|
|
|
245,045 |
|
|
|
|
9/30/08 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
150,000 |
(6) |
|
|
1.235 |
|
|
|
1.25 |
|
|
|
88,830 |
|
|
Kevin L. Kemmerer |
|
|
4/22/08 |
|
|
|
|
|
|
|
309,583 |
|
|
|
464,375 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6/30/08 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
375,000 |
(7) |
|
|
1.275 |
|
|
|
1.24 |
|
|
|
281,571 |
|
|
|
|
6/30/08 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
125,000 |
(6) |
|
|
1.275 |
|
|
|
1.24 |
|
|
|
78,563 |
|
|
|
|
9/30/08 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
375,000 |
(5) |
|
|
1.235 |
|
|
|
1.25 |
|
|
|
204,204 |
|
|
|
|
9/30/08 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
125,000 |
(6) |
|
|
1.235 |
|
|
|
1.25 |
|
|
|
74,025 |
|
|
Brian J. Sisko |
|
|
4/22/08 |
|
|
|
|
|
|
|
250,000 |
|
|
|
375,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9/30/08 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98,500 |
(5) |
|
|
1.235 |
|
|
|
1.25 |
|
|
|
53,638 |
|
|
|
|
9/30/08 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31,500 |
(6) |
|
|
1.235 |
|
|
|
1.25 |
|
|
|
18,654 |
|
|
Stephen T. Zarrilli |
|
|
6/30/08 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,125,000 |
(7) |
|
|
1.275 |
|
|
|
1.24 |
|
|
|
844,713 |
|
|
|
|
6/30/08 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
375,000 |
(6) |
|
|
1.275 |
|
|
|
1.24 |
|
|
|
235,688 |
|
|
|
|
9/30/08 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
26,250 |
(5) |
|
|
1.235 |
|
|
|
1.25 |
|
|
|
14,294 |
|
|
|
|
9/30/08 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,750 |
(6) |
|
|
1.235 |
|
|
|
1.25 |
|
|
|
5,182 |
|
|
Raymond J. Land |
|
|
4/22/08 |
|
|
|
|
|
|
|
195,000 |
|
|
|
292,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
These awards were made under the 2008 MIP. There were no mandatory minimum awards payable
under the 2008 MIP and the maximum awards payable were 150% of the target amounts. The
amounts in the table represent payouts that might have been achieved based on performance at
target or maximum performance levels. Mr. Land voluntarily resigned in May 2008 and was not
eligible for a payment under this plan. The cash amounts actually paid under this plan for
2008 have been reported in the Summary Compensation Table under Non-Equity Incentive Plan
Compensation. As described in detail under Compensation Discussion and Analysis 2008
Compensation Program, the Compensation Committee determined
that amounts earned under the 2008 MIP by our named executive officers would be paid 50% in cash and 50% in
restricted stock. The restricted stock was issued in February 2009, is subject to vesting over
a three-year period, and will be reported in the tables that will be included in our 2010 proxy
statement. |
24
|
|
|
(2) |
|
The options have an eight-year term. Vesting of equity awards may be accelerated upon death,
permanent disability, retirement on or after 65th birthday, termination of
employment for good reason or without cause, or termination of employment in connection with a
change in control, and, in the case of Mr. Bonis stock options, upon the occurrence of a
change in control. Further information regarding the equity awards that are subject to
acceleration of vesting in each circumstance can be found below under Potential Payments upon
Termination or Change in Control. |
|
(3) |
|
The market price reported in this column is the closing price of Safeguard common stock as
reported on the NYSE composite tape on the grant date. Under the terms of Safeguards equity
compensation plans, the exercise price of an option is determined based upon the average of
the high and low trading prices of Safeguards common stock as reported on the NYSE composite
tape on the grant date. |
|
(4) |
|
The amounts in this column represent the grant date fair value of the awards computed in
accordance with FAS 123(R). For a discussion of the valuation assumptions, see footnote 2 to
the Summary Compensation Table. |
|
(5) |
|
As described in detail under Compensation Discussion and Analysis Long-Term Incentives,
these options are subject to performance-based vesting and vest based on the aggregate cash
produced as a result of exit transactions involving certain of our partner companies relative
to the amount of cash deployed in connection with such partner companies. |
|
(6) |
|
These options vest as to 25% of the underlying shares on the first anniversary date of the
grant date and as to the remaining 75% of the underlying shares in 36 equal monthly
installments thereafter. |
|
(7) |
|
These options are subject to market-based vesting and vest upon the achievement of the
following per share stock price levels (based on the average closing price of a share of our
common stock as reported on the NYSE composite tape for 20 consecutive trading days): |
|
|
|
|
|
Percentage of Shares |
|
Per Share Stock |
|
Underlying Options That Vest |
|
Price |
|
First 20% |
|
$ |
3.1548 |
|
Next 30% |
|
$ |
4.6466 |
|
Next 40% |
|
$ |
6.5114 |
|
Final 10% |
|
$ |
7.2246 |
|
In addition to vesting upon the achievement of a specified per share stock price level, the
shares underlying the options may vest on a pro rata basis on each six-month anniversary of the
grant date if the per share stock price is between the designated levels (based on the highest
average closing price of a share of our common stock as reported on the NYSE composite tape for
20 consecutive trading days during each six-month period).
25
Outstanding Equity Awards at Fiscal Year-End 2008
The following table shows the equity awards we have made to our named executive officers that were
outstanding at December 31, 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards |
|
|
Stock Awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of |
|
|
Number of |
|
|
Number of |
|
|
|
|
|
|
|
|
|
|
Number of |
|
|
|
|
|
|
|
|
|
|
Securities |
|
|
Securities |
|
|
Securities |
|
|
|
|
|
|
|
|
|
|
Shares or |
|
|
Market Value |
|
|
|
|
|
|
|
Underlying |
|
|
Underlying |
|
|
Underlying |
|
|
|
|
|
|
|
|
|
|
Units of |
|
|
of Shares or |
|
|
|
|
|
|
|
Unexercised |
|
|
Unexercised |
|
|
Unexercised |
|
|
Option |
|
|
|
|
|
|
Stock That |
|
|
Units of Stock |
|
|
|
|
|
|
|
Options |
|
|
Options |
|
|
Unearned |
|
|
Exercise |
|
|
Option |
|
|
Have Not |
|
|
That Have |
|
|
|
Grant |
|
|
(#)(1) |
|
|
(#)(1)(2) |
|
|
Options |
|
|
Price |
|
|
Expiration |
|
|
Vested |
|
|
Not Vested |
|
Name |
|
Date |
|
|
Exercisable |
|
|
Unexercisable |
|
|
(#)(2) |
|
|
($) |
|
|
Date |
|
|
(#) |
|
|
($) |
|
Peter J. Boni |
|
|
08/16/05 |
|
|
|
833,333 |
|
|
|
166,667 |
|
|
|
|
|
|
|
1.275 |
|
|
|
08/16/13 |
|
|
|
|
|
|
|
|
|
|
|
|
08/16/05 |
|
|
|
861,245 |
|
|
|
|
|
|
|
2,138,755 |
(3) |
|
|
1.275 |
|
|
|
08/16/13 |
|
|
|
|
|
|
|
|
|
|
|
|
09/30/08 |
|
|
|
|
|
|
|
300,000 |
|
|
|
|
|
|
|
1.235 |
|
|
|
09/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
09/30/08 |
|
|
|
|
|
|
|
|
|
|
|
900,000 |
(4) |
|
|
1.235 |
|
|
|
09/30/16 |
|
|
|
|
|
|
|
|
|
|
James A. Datin |
|
|
09/07/05 |
|
|
|
406,250 |
|
|
|
93,750 |
|
|
|
|
|
|
|
1.560 |
|
|
|
09/07/13 |
|
|
|
|
|
|
|
|
|
|
|
|
09/07/05 |
|
|
|
430,622 |
|
|
|
|
|
|
|
1,069,378 |
(3) |
|
|
1.560 |
|
|
|
09/07/13 |
|
|
|
|
|
|
|
|
|
|
|
|
09/30/08 |
|
|
|
|
|
|
|
150,000 |
|
|
|
|
|
|
|
1.235 |
|
|
|
09/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
09/30/08 |
|
|
|
|
|
|
|
|
|
|
|
450,000 |
(4) |
|
|
1.235 |
|
|
|
09/30/16 |
|
|
|
|
|
|
|
|
|
|
Kevin L. Kemmerer |
|
|
06/14/04 |
|
|
|
100,000 |
|
|
|
|
|
|
|
|
|
|
|
2.335 |
|
|
|
06/14/12 |
|
|
|
|
|
|
|
|
|
|
|
|
12/15/04 |
|
|
|
125,000 |
|
|
|
|
|
|
|
|
|
|
|
2.125 |
|
|
|
12/15/12 |
|
|
|
|
|
|
|
|
|
|
|
|
06/06/05 |
|
|
|
21,875 |
|
|
|
3,125 |
|
|
|
|
|
|
|
1.030 |
|
|
|
06/06/13 |
|
|
|
|
|
|
|
|
|
|
|
|
10/25/05 |
|
|
|
39,583 |
|
|
|
10,417 |
|
|
|
|
|
|
|
1.380 |
|
|
|
10/25/13 |
|
|
|
|
|
|
|
|
|
|
|
|
10/25/05 |
|
|
|
114,832 |
|
|
|
|
|
|
|
285,168 |
(3) |
|
|
1.380 |
|
|
|
10/25/13 |
|
|
|
|
|
|
|
|
|
|
|
|
02/12/06 |
|
|
|
86,124 |
|
|
|
|
|
|
|
213,876 |
(3) |
|
|
1.975 |
|
|
|
02/21/14 |
|
|
|
|
|
|
|
|
|
|
|
|
06/30/08 |
|
|
|
|
|
|
|
125,000 |
|
|
|
|
|
|
|
1.275 |
|
|
|
06/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
06/30/08 |
|
|
|
|
|
|
|
|
|
|
|
375,000 |
(5) |
|
|
1.275 |
|
|
|
06/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
09/30/08 |
|
|
|
|
|
|
|
125,000 |
|
|
|
|
|
|
|
1.235 |
|
|
|
09/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
09/30/08 |
|
|
|
|
|
|
|
|
|
|
|
375,000 |
(4) |
|
|
1.235 |
|
|
|
09/30/16 |
|
|
|
|
|
|
|
|
|
|
Brian J. Sisko |
|
|
08/20/07 |
|
|
|
83,333 |
|
|
|
166,667 |
|
|
|
|
|
|
|
2.106 |
|
|
|
08/20/15 |
|
|
|
|
|
|
|
|
|
|
|
|
08/20/07 |
|
|
|
40,618 |
|
|
|
|
|
|
|
709,382 |
(5) |
|
|
2.106 |
|
|
|
08/20/15 |
|
|
|
|
|
|
|
|
|
|
|
|
09/30/08 |
|
|
|
|
|
|
|
31,500 |
|
|
|
|
|
|
|
1.235 |
|
|
|
09/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
09/30/08 |
|
|
|
|
|
|
|
|
|
|
|
98,500 |
(4) |
|
|
1.235 |
|
|
|
09/30/16 |
|
|
|
|
|
|
|
|
|
|
Stephen T. Zarrilli |
|
|
12/15/06 |
|
|
|
150,000 |
|
|
|
|
|
|
|
|
|
|
|
2.335 |
|
|
|
06/11/10 |
|
|
|
|
|
|
|
|
|
|
|
|
06/30/08 |
|
|
|
|
|
|
|
375,000 |
|
|
|
|
|
|
|
1.275 |
|
|
|
06/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
06/30/08 |
|
|
|
|
|
|
|
|
|
|
|
1,125,000 |
(5) |
|
|
1.275 |
|
|
|
06/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
09/30/08 |
|
|
|
|
|
|
|
8,750 |
|
|
|
|
|
|
|
1.235 |
|
|
|
09/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
09/30/08 |
|
|
|
|
|
|
|
|
|
|
|
26,250 |
(4) |
|
|
1.235 |
|
|
|
09/30/16 |
|
|
|
|
|
|
|
|
|
|
Raymond J. Land (6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Unless otherwise identified by footnote, options are subject to time-based vesting, with 25%
of the underlying shares vesting on the first anniversary date of the grant date and the
remaining underlying shares vesting in 36 equal installments on the same date of each month
thereafter. |
|
(2) |
|
Vesting of equity awards may be accelerated upon death, permanent disability, retirement on
or after 65th birthday, termination of employment for good reason or without cause,
or termination of employment in connection with a change in control, and, in the case of Mr.
Bonis equity awards, upon the occurrence of a change in control. Further information
regarding the equity awards that are subject to acceleration of vesting in each circumstance
can be found below under Potential Payments upon Termination or Change in Control. |
26
|
|
|
(3) |
|
These options are market-based vesting options and vest upon the achievement of improvement
in Safeguards stock price. Achievement is measured based on the average daily closing price
of Safeguard common stock as reported on the NYSE composite tape for 20 consecutive trading
days. The following table shows the per share stock prices at which portions of the shares
underlying these market-based vesting options vest: |
|
|
|
|
|
Percentage of Shares |
|
|
|
Underlying Options that Vest |
|
Per Share Stock Price |
|
First 10% |
|
$ |
2.0359 |
|
Next 20% |
|
|
3.1548 |
|
Next 30% |
|
|
4.6466 |
|
Final 40% |
|
|
6.5114 |
|
|
|
|
|
|
In addition to vesting upon the achievement of a specified per share stock price, the shares
underlying the options may vest on a pro rata basis on each six-month anniversary of the grant
date if the per share stock price is between the designated stock prices (based on the highest
average closing price of a share of our common stock as reported on the NYSE composite tape for
20 consecutive trading days during each six-month period). |
|
(4) |
|
As described in detail under Compensation Discussion and Analysis Long-Term Incentives,
these options are subject to performance-based vesting and vest based on the aggregate cash
produced as a result of exit transactions involving certain of our partner companies relative
to the amount of cash deployed in connection with such partner companies. |
|
(5) |
|
These options are market-based vesting options and vest upon the achievement of improvement
in Safeguards stock price. Achievement is measured based on the average daily closing price
of Safeguard common stock as reported on the NYSE composite tape for 20 consecutive trading
days. The following table shows the per share stock prices at which portions of the shares
underlying these market-based vesting options vest: |
|
|
|
|
|
Percentage of Shares |
|
|
|
Underlying Options that Vest |
|
Per Share Stock Price |
|
First 20% |
|
$ |
3.1548 |
|
Next 30% |
|
|
4.6466 |
|
Next 40% |
|
|
6.5114 |
|
Final 10% |
|
|
7.2246 |
|
|
|
|
|
|
In addition to vesting upon the achievement of a specified per share stock price, the shares
underlying the options may vest on a pro rata basis on each six-month anniversary of the grant
date if the per share stock price is between the designated stock prices (based on the highest
average closing price of a share of our common stock as reported on the NYSE composite tape for
20 consecutive trading days during each six-month period). |
|
(6) |
|
Mr. Lands options terminated following his voluntary resignation in May 2008. |
Option Exercises and Stock Vested 2008
There were no stock options exercised by our named executive officers during 2008 and there were no
restricted stock awards held by any named executive officers during 2008.
Nonqualified Deferred Compensation 2008
In 2003, Safeguard adopted an Executive Deferred Compensation Plan, which is a nonqualified,
unfunded plan that provides for a designated group of employees to obtain credits in the form of
Safeguard contributions that are allocated to accounts for the benefit of each participant.
Participants may not defer compensation under the plan. This plan was adopted in order to
approximate matching contributions under our 401(k) plan which, based upon the terms and structure
of our 401(k) plan, were not available to our most highly compensated personnel.
Contributions by Safeguard are discretionary and may vary from year to year. For 2008, we credited
each eligible participants account with an amount equal to 4% of up to $230,000 of the
participants 2008 salary and bonus (which amount was fully vested) and 3.5% of up to $230,000 of
the participants 2008 base salary (which amount vests 20% for each year of service in which the
participant has attained 1,000 hours of service).
27
Lump sum distributions of the vested balance in a named executive officers account are made
following termination of employment as follows:
|
|
Amounts that were earned and vested at December 31, 2005, are distributed within 30
business days following termination; and |
|
|
The remaining amount is distributed six months following termination. |
A committee appointed by Safeguards Board selects the funds or indices that are used for purposes
of calculating the earnings that are credited to each participants account based on a notional
investment in the selected funds or indices. Since the plans inception, we have calculated
earnings based on the performance of the notional investment in the Principal Investors Fund, Inc.
Large-Cap S&P 500 Index Fund (PLFPX), which is one of the investment choices that had been
available to participants in Safeguards 401(k) plan. The committee, in its discretion, may
replace this fund and add new funds.
The following table shows contributions and earnings for 2008 and account balances at December 31,
2008, for the named executive officers. There were no withdrawals or distributions by the named
executive officers during 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Registrant |
|
|
|
|
|
|
|
|
|
|
|
|
Contributions in Last |
|
|
Aggregate Earnings |
|
|
Aggregate Withdrawals/ |
|
|
Aggregate Balance |
|
|
|
Fiscal Year |
|
|
in Last Fiscal Year |
|
|
Distributions |
|
|
at Last Fiscal Year End |
|
Name |
|
($)(1) |
|
|
($)(1) |
|
|
($) |
|
|
($)(2)(3) |
|
Peter J. Boni |
|
|
17,250 |
|
|
|
(16,070 |
) |
|
|
|
|
|
|
35,380 |
|
James A. Datin |
|
|
17,250 |
|
|
|
(16,070 |
) |
|
|
|
|
|
|
35,380 |
|
Kevin L. Kemmerer |
|
|
17,250 |
|
|
|
(22,622 |
) |
|
|
|
|
|
|
47,952 |
|
Brian J. Sisko |
|
|
17,250 |
|
|
|
|
|
|
|
|
|
|
|
17,250 |
|
Stephen T. Zarrilli |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Raymond J. Land |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Contributions are included in the Summary Compensation Table under All Other Compensation.
Earnings in the last fiscal year are included in the Summary Compensation Table
under Change in Pension Value and Nonqualified Deferred Compensation Earnings. |
|
(2) |
|
The balance in each named executive officers account consists of contributions credited by
us and notional accrued gains or losses. In prior years, the amounts credited by us under
this plan for the benefit of named executive officers were reported in our proxy statement as
compensation in the Summary Compensation Table. |
|
(3) |
|
At December 31, 2008, Mr. Kemmerer was fully vested, and Messrs. Boni, Datin and Sisko had
vested account balances of $28,776, $28,776 and $10,810, respectively. |
Potential Payments upon Termination or Change in Control
Messrs. Boni, Datin, Kemmerer, Sisko and Zarrilli each have agreements with us which provide for
certain benefits upon termination of employment without cause or for good reason, either
involuntarily or in connection with a change in control. Under these agreements, the following
definitions apply:
28
|
|
|
|
|
Cause
|
|
à
|
|
Violation of any of our written policies; appropriation of a material
business opportunity of our company; misappropriation of company
assets; conviction of a felony or any other crime with respect to which
imprisonment is a possible punishment; or breach of any material term
of the executives employment agreement or any other agreement with, or
duty owed to, us or any of our partner companies. |
|
|
|
|
|
Good Reason
|
|
à
|
|
A material diminution, without the executives consent, in the nature
or status of the executives position, title, reporting relationship,
duties, responsibilities or authority; a material reduction of the
executives base salary; a material breach by us of the executives
agreement; the relocation of our principal office by more than 30 to 35
miles; or an executives assignment, without his consent, to be based
anywhere other than our principal office. |
|
|
|
|
|
Change in Control
|
|
à
|
|
A change in control generally occurs when: |
|
|
|
A person becomes the beneficial owner of securities having 50%
or more of the combined voting power of our securities; |
|
|
|
|
Less than a majority of our Board consists of continuing
directors (which means a director who either is a member of the Board
as of the effective date of the change in control or is nominated or
appointed to serve as a director by a majority of the then continuing
directors); |
|
|
|
|
We are subject to a merger or other business combination
transaction as a result of which holders of a majority of our equity
securities do not own a majority of the equity securities of the
surviving company; |
|
|
|
|
We sell all or substantially all of our assets or are
liquidated. |
Payments Made upon Involuntary Termination of Employment without Cause or for Good Reason
Messrs. Boni, Datin, Kemmerer, Sisko and Zarrilli will receive the following benefits upon
involuntary termination of employment without cause or for good reason:
|
|
Messrs. Boni, Datin and Kemmerer: |
|
|
|
A lump sum payment equal to the executives then current annual base salary and the
greater of the executives target bonus (not less than 100% of current base salary) for the
year of termination or the average of the executives actual bonuses for the last three
completed fiscal years; |
|
|
|
|
All vested stock options will remain exercisable for 12 months; and |
|
|
|
|
12 months continued coverage under our medical and dental plans. |
|
|
Messrs. Sisko and Zarrilli: |
|
|
|
A lump sum payment equal to 1.5 times the executives then current base salary and the
executives earned prorated bonus for the year of termination (commencing in 2009 for Mr.
Zarrilli); |
|
|
|
|
All time-vested stock options will fully vest and remain exercisable for 36 months and
vested performance-based stock options will remain exercisable for 12
months; |
|
|
|
|
12 months continued coverage under our medical, dental and life insurance plans; and |
|
|
|
|
Up to $20,000 for outplacement services or office space. |
Payments Made upon a Change in Control or Involuntary Termination of Employment without Cause or
for Good Reason in Connection with a Change in Control
Upon a change in control, the stock options held by Mr. Boni that have not otherwise vested will
become fully vested. Our named executive officers will not be entitled to any other payments or
benefits (except those that are provided on a non-discriminatory basis to our employees generally
upon termination of employment) unless the change in control is coupled with a loss of employment
or a substantial change in job duties as described above.
29
Upon involuntary termination of employment without cause or for good reason within six months
before or 12 months following a change in control (for Messrs. Boni, Datin and Kemmerer) or within
18 months following a change in control (for Messrs. Sisko and Zarrilli), Messrs. Boni, Datin,
Kemmerer, Sisko and Zarrilli will receive the following benefits:
|
|
Messrs. Boni, Datin and Kemmerer: |
|
|
|
A lump sum payment equal to a multiple of the executives then current base salary and
a multiple of the greater of the executives target bonus (not less than 100% of current
base salary) for the year of termination or the average of the executives actual bonuses
for the last three completed fiscal years (the multiple is three times for Mr. Boni and two
times for Messrs. Datin and Kemmerer); |
|
|
|
|
All stock options that have not otherwise vested will fully vest and will remain
exercisable for 36 months for Mr. Boni and 24 months for Messrs. Datin and Kemmerer; and |
|
|
|
|
Continued coverage under our medical and dental plans for 36 months for Mr. Boni and 24
months for Messrs. Datin and Kemmerer. |
|
|
Messrs. Sisko and Zarrilli: |
|
|
|
A lump sum payment equal to 1.5 times the executives then current base salary and the
executives earned prorated bonus for the year of termination (commencing in 2009 for Mr.
Zarrilli); |
|
|
|
|
All time-vested stock options will fully vest and remain exercisable for 36 months and
all performance-based stock options that have not otherwise vested will
vest and remain exercisable for 24 months; |
|
|
|
|
12 months continued coverage under our medical, health and life insurance plans; and |
|
|
|
|
Up to $20,000 for outplacement services or office space. |
Other Payments Made upon Termination of Employment
Regardless of the manner in which a named executive officers employment terminates, he also
generally will receive payments and benefits that are provided on a non-discriminatory basis to our
employees upon termination of employment, including the following:
|
|
Amounts earned during his term of employment; |
|
|
Upon his death, disability or voluntary termination of employment, his accrued unused
vacation pay; |
|
|
Amounts contributed by us for the year of termination under our 401(k) plan or nonqualified
deferred compensation plan (if he has completed the required hours of service, if any, and is
an employee on the date as of which we make a contribution); |
|
|
Distribution of accrued and vested plan balances under our 401(k) plan and nonqualified
deferred compensation plan; |
|
|
Reimbursement of eligible dental expenses for services incurred prior to termination; |
|
|
Upon his death, disability or retirement on or after his 65th birthday, accelerated vesting
of stock options subject to time-based vesting that have not otherwise vested and extension of
the post-termination exercise period for all stock options from 90 days to 12 months; and |
|
|
Upon his death or disability, accelerated vesting of restricted stock awards that have not
otherwise vested; and |
|
|
Upon his death or disability, payment of benefits under our other broad-based employee
benefit programs, including short-term and long-term disability plans, life insurance program,
accidental death and dismemberment plan and business travel insurance plan, as applicable. |
The following table shows the potential incremental payments and benefits which the named executive
officers would have been entitled to receive during 2008 upon termination of employment in each
situation listed in the table below under their respective agreements and our broad-based employee
benefit programs. The amounts shown do not include certain payments and benefits available
generally to salaried employees upon termination of employment, such as distributions from our
401(k) and deferred compensation plans. The amounts shown in the table are based on an assumed
termination as of December 31, 2008 and represent estimates of the maximum incremental amounts and
benefits that would have been paid to each executive upon his termination which we have calculated:
(i) by multiplying the 2008 annualized base salary for each named executive officer by
30
the
multiplier in each scenario that is specified in each such executives agreement with us; (ii) for Messrs. Boni, Datin and Kemmerer, by
multiplying their respective 2008 target incentive awards by the multiplier in each scenario that
is specified in their respective agreements with us; (iii) for Messrs. Sisko and Zarrilli, by
assuming they would have been entitled to their respective 2008 annualized target incentive award
for the full year; and (iv) by using our 2009 premium costs for calculating the value of the health
and welfare benefits. Mr. Land has been excluded from this table because he received no severance
benefits or payments in connection with his voluntary resignation in May 2008. The actual amounts
to be paid to each executive would depend on the time and circumstances of an executives
separation from Safeguard.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life Insurance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued |
|
|
Proceeds or |
|
|
Health and |
|
|
Acceleration |
|
|
Total |
|
|
|
Salary and |
|
|
Vacation |
|
|
Disability |
|
|
Welfare |
|
|
of Equity |
|
|
Termination |
|
|
|
Bonus |
|
|
Pay |
|
|
Income |
|
|
Benefits |
|
|
Awards |
|
|
Benefits |
|
Current |
|
($) |
|
|
($) |
|
|
($) |
|
|
($) |
|
|
($)(1) |
|
|
($) |
|
Peter J. Boni |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Normal Retirement
(65+) |
|
|
|
|
|
|
6,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,250 |
|
Permanent disability |
|
|
|
|
|
|
6,250 |
|
|
|
741,880 |
|
|
|
|
|
|
|
|
|
|
|
748,130 |
|
Death |
|
|
|
|
|
|
6,250 |
|
|
|
1,500,000 |
|
|
|
|
|
|
|
|
|
|
|
1,506,250 |
|
Involuntary
termination without cause or
for good reason |
|
|
1,300,000 |
|
|
|
|
|
|
|
|
|
|
|
11,910 |
|
|
|
|
|
|
|
1,311,910 |
|
Change in control |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change-in-control
termination, involuntarily or
for good reason |
|
|
3,900,000 |
|
|
|
|
|
|
|
|
|
|
|
35,730 |
|
|
|
|
|
|
|
3,935,730 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
James A. Datin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Normal Retirement
(65+) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Permanent disability |
|
|
|
|
|
|
|
|
|
|
4,493,385 |
|
|
|
|
|
|
|
|
|
|
|
4,493,385 |
|
Death |
|
|
|
|
|
|
|
|
|
|
750,000 |
|
|
|
|
|
|
|
|
|
|
|
750,000 |
|
Involuntary
termination without cause or
for good reason |
|
|
780,000 |
|
|
|
|
|
|
|
|
|
|
|
15,940 |
|
|
|
|
|
|
|
795,940 |
|
Change-in-control
termination, involuntarily or
for good reason |
|
|
1,560,000 |
|
|
|
|
|
|
|
|
|
|
|
31,880 |
|
|
|
|
|
|
|
1,591,880 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kevin L. Kemmerer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Normal Retirement
(65+) |
|
|
|
|
|
|
3,750 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,750 |
|
Permanent disability |
|
|
|
|
|
|
3,750 |
|
|
|
3,515,363 |
|
|
|
|
|
|
|
|
|
|
|
3,519,113 |
|
Death |
|
|
|
|
|
|
3,750 |
|
|
|
750,000 |
|
|
|
|
|
|
|
|
|
|
|
753,750 |
|
Involuntary
termination without cause or
for good reason |
|
|
650,000 |
|
|
|
|
|
|
|
|
|
|
|
15,940 |
|
|
|
|
|
|
|
665,940 |
|
Change-in-control
termination, involuntarily or
for good reason |
|
|
1,300,000 |
|
|
|
|
|
|
|
|
|
|
|
31,880 |
|
|
|
|
|
|
|
1,331,880 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brian J. Sisko |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Normal Retirement
(65+) |
|
|
|
|
|
|
3,923 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,923 |
|
Permanent disability |
|
|
|
|
|
|
3,923 |
|
|
|
3,494,010 |
|
|
|
|
|
|
|
|
|
|
|
3,497,933 |
|
Death |
|
|
|
|
|
|
3,923 |
|
|
|
750,000 |
|
|
|
|
|
|
|
|
|
|
|
753,923 |
|
Involuntary
termination without cause or
for good reason |
|
|
760,000 |
|
|
|
|
|
|
|
|
|
|
|
45,432 |
|
|
|
|
|
|
|
805,432 |
|
Change-in-control
termination, involuntarily or
for good reason |
|
|
760,000 |
|
|
|
|
|
|
|
|
|
|
|
45,432 |
|
|
|
|
|
|
|
805,432 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stephen T. Zarrilli |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Normal Retirement
(65+) |
|
|
|
|
|
|
3,923 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,923 |
|
Permanent disability |
|
|
|
|
|
|
3,923 |
|
|
|
3,605,700 |
|
|
|
|
|
|
|
|
|
|
|
3,609,623 |
|
Death |
|
|
|
|
|
|
3,923 |
|
|
|
750,000 |
|
|
|
|
|
|
|
|
|
|
|
753,923 |
|
Involuntary
termination without cause or
for good reason |
|
|
760,000 |
|
|
|
|
|
|
|
|
|
|
|
45,451 |
|
|
|
|
|
|
|
805,451 |
|
Change-in-control
termination, involuntarily or
for good reason |
|
|
760,000 |
|
|
|
|
|
|
|
|
|
|
|
45,451 |
|
|
|
|
|
|
|
805,451 |
|
|
|
|
(1) |
|
Under SEC rules, the expense related to the acceleration of equity awards is calculated based
on the number of shares underlying stock options for which vesting would have been accelerated
as of December 31, 2008, in each scenario, multiplied by the difference between our year-end
closing stock price, as reported on the NYSE composite tape, and the exercise price of stock
options for which vesting would have been accelerated. At December 31, 2008, all of the stock
options held by our named executive officers had exercise prices in excess of our year-end
closing stock price. |
31
DIRECTOR COMPENSATION
During 2008, each of our non-employee directors was compensated for his or her service as a
director as shown in the table below:
|
|
|
|
|
Compensation Item |
|
Amount |
|
Annual Board Retainers: |
|
|
|
|
Chairman of the Board |
|
$ |
50,000 |
|
Other Directors |
|
|
35,000 |
|
Additional Annual Chairperson Retainers: |
|
|
|
|
Audit Committee |
|
|
15,000 |
|
Compensation Committee |
|
|
7,500 |
|
Nominating & Corporate Governance Committee |
|
|
5,000 |
|
Meeting Attendance Fees: |
|
|
|
|
Board |
|
|
2,000 |
|
Committee |
|
|
1,500 |
|
In light of Safeguards efforts to conserve cash resources in the current economic climate and
managements commitment to Safeguards efforts to increase shareholder value, the Board implemented
for 2009 a requirement that each director defer at least 25% of the retainer and meeting fees
payable to each director for service on the Safeguard Board and its committees during 2009.
Directors will receive deferred stock units in lieu of such deferred fees as more fully described
below.
We also reimburse our directors for expenses they incur to attend our Board and Committee meetings
and for attendance at one directors continuing education program during each calendar year or the
reasonable cost of one years membership in an organization which is focused on director education.
At the request of Safeguard, non-employee directors of Safeguard also may, from time to time, be
asked to act as Safeguards designated member on the Board of Directors of a Safeguard partner
company. In exchange for providing such board service, Safeguard will directly compensate each
such director on a per meeting basis at rates ranging from $500 to $2,000 for attendance at each
in-person meeting or telephonic board meeting. Safeguard also will reimburse each such director
for all out-of-pocket expenses incurred by him or her in connection with such service, subject to
being reimbursed by the particular partner company as circumstances dictate.
Each director who is not an employee of Safeguard receives an initial option grant to purchase
50,000 shares of Safeguard common stock upon the earlier of the date of Safeguards annual meeting
of shareholders or at the end of the quarter following the directors initial election to the
Board. Directors also receive recurring annual service grants. Recurring annual service grants to
directors, which previously had generally been made in December of each year, have been awarded,
since 2007, on the date of Safeguards annual meeting of shareholders as a matter of best practice.
Since 2005, the recurring annual service grant has consisted of a stock option grant to purchase
25,000 shares of Safeguard common stock. Starting in 2008, as part of the annual service grant,
directors also received 12,500 deferred stock units, as more fully described below, in addition to
the stock option grant. Directors stock options have an eight-year term. Initial stock option
grants vest as to 25% of the underlying shares on each of the first four anniversaries of the grant
date. Annual service stock option and deferred stock unit grants fully vest on the first
anniversary of the grant date or, if earlier, once a director reaches age 65. The exercise price
of stock options is equal to the average of the high and low trading prices of our common stock, as
reported on the NYSE composite tape, on the grant date. The deferred stock units represent the
right to receive shares of Safeguard common stock, on a one-for-one basis, on or about the first
anniversary of the date upon which the director leaves the Safeguard Board. On July 23, 2008, each
non-employee director received an annual service grant of stock options to purchase 25,000 shares
at an exercise price of $1.19 per share and 12,500 deferred stock units.
32
Safeguard also maintains a Group Deferred Stock Unit Program for Directors (Directors DSU
Program) which allows each director, at his or her election, to receive deferred stock units in
lieu of retainer and meeting fees paid to directors for service on the Safeguard Board (Directors
Fees). The deferral election applies to Directors Fees to be received for the calendar year
following the year in which the election is made and remains in effect for each subsequent year
unless the director elects otherwise by the end of the calendar year prior to the year in which the
services are rendered. The number of deferred stock units awarded is determined by dividing the
Directors Fees by the fair market value of Safeguards stock on the date on which the director
would have otherwise received the
Directors Fees. Each director also receives a number of matching share units, based on the same
fair market value calculation, equal to 25% of the Directors Fees deferred. A director is always
fully vested in Directors Fees deferred; the matching share units vest fully on the first
anniversary of the date the matching share units are credited to the directors account or, if
earlier, once a director reaches age 65. Each deferred stock unit entitles the director to receive
one share of Safeguard common stock on or about the first anniversary of the date upon which the
director leaves the Safeguard Board. A director also may elect to receive the stock in annual
installments over a period of up to five years after leaving the Board.
Director Compensation 2008. The following table provides information on compensation earned
during 2008 by each non-employee director who served on our Board at any time during 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees Earned or |
|
|
Stock |
|
|
Option |
|
|
All Other |
|
|
|
|
|
|
Paid in Cash |
|
|
Awards |
|
|
Awards |
|
|
Compensation |
|
|
Total |
|
Name |
|
($)(1) |
|
|
($)(2)(3)(5) |
|
|
($)(3)(4)(5) |
|
|
($)(6) |
|
|
($)(7) |
|
Michael J. Cody |
|
$ |
76,500 |
|
|
$ |
6,561 |
|
|
$ |
37,890 |
|
|
$ |
1,512 |
|
|
$ |
122,463 |
|
Julie A. Dobson |
|
|
95,000 |
|
|
|
11,295 |
|
|
|
21,209 |
|
|
|
|
|
|
|
127,504 |
|
Robert E. Keith, Jr. |
|
|
70,500 |
|
|
|
34,249 |
|
|
|
14,265 |
|
|
|
|
|
|
|
119,014 |
|
Andrew E. Lietz |
|
|
70,000 |
|
|
|
14,875 |
|
|
|
14,265 |
|
|
|
|
|
|
|
99,140 |
|
George MacKenzie |
|
|
98,000 |
|
|
|
6,561 |
|
|
|
21,209 |
|
|
|
673 |
|
|
|
126,443 |
|
George D. McClelland |
|
|
102,500 |
|
|
|
27,922 |
|
|
|
36,487 |
|
|
|
1,200 |
|
|
|
168,109 |
|
Jack L. Messman |
|
|
63,500 |
|
|
|
27,313 |
|
|
|
14,265 |
|
|
|
|
|
|
|
105,078 |
|
John W. Poduska, Sr. |
|
|
69,000 |
|
|
|
14,875 |
|
|
|
14,265 |
|
|
|
|
|
|
|
98,140 |
|
John J. Roberts |
|
|
87,000 |
|
|
|
6,561 |
|
|
|
21,209 |
|
|
|
|
|
|
|
114,770 |
|
Robert J. Rosenthal (8) |
|
|
86,000 |
|
|
|
6,561 |
|
|
|
22,774 |
|
|
|
1,500 |
|
|
|
116,835 |
|
|
|
|
(1) |
|
Ms. Dobson deferred payment of 25%, and Messrs. Keith, McClelland and Messman each deferred
payment of 100%, of Directors Fees they earned for services provided during 2008. Ms. Dobson
and Messrs. Keith, McClelland and Messman each received deferred stock units in lieu of
Directors Fees that they deferred and matching deferred stock units equal to 25% of the
Directors Fees that they deferred. Directors who defer fees and receive deferred stock units
are essentially investing in common stock equivalents that are initially valued based on the
current market value of our common stock on the date of issuance. As a result, the value of
their deferred stock units fluctuates with the market value of our common stock. Includes
$2,500 and $19,500 paid to Mr. Cody and Ms. Dobson, respectively, for attending meetings as
Safeguards designated member on the board of directors of two Safeguard partner companies. |
|
(2) |
|
These amounts do not represent compensation actually received. Rather, these amounts
represent the aggregate expense we recognized for financial statement reporting purposes for
the fiscal year ended December 31, 2008 for the deferred stock units awarded during and prior
to 2008, in accordance with Statement of Financial Accounting Standards No. 123 (revised),
which we refer to as FAS 123(R). In accordance with SEC rules, the amounts shown exclude
the effect of estimated forfeitures related to service-based vesting conditions. Other than
for deferred stock units which are received in lieu of Directors Fees that have been
deferred, the fair value of the deferred stock units is determined by multiplying the number
of shares underlying the deferred stock units by the average of the high and low trading
prices of Safeguards common stock, as reported on the NYSE composite tape, on the grant date.
The grant date fair values of the deferred stock units issued during 2008 were as follows:
Messrs. Cody, Lietz, MacKenzie, Poduska, Roberts and Rosenthal $14,875 each; Ms. Dobson
$19,845; Mr. Keith $34,249; Mr. McClelland $40,750; Mr. Messman $27,313. A portion of
the matching deferred stock units issued during 2008 to Ms. Dobson and Messrs. Keith and
McClelland related to fees deferred by them that were earned during the fourth quarter of
2007. For a discussion of valuation assumptions, see footnote 2 to the Summary Compensation
Table under the heading Executive Compensation. |
33
(3) |
|
The directors aggregate holdings of deferred stock units and stock options to purchase
shares of our common stock (both vested and unvested), as of December 31, 2008, were as
follows: |
|
|
|
|
|
|
|
|
|
|
|
Deferred |
|
|
|
|
Name |
|
Stock Units |
|
|
Stock Options |
|
Michael J. Cody |
|
|
12,500 |
|
|
|
125,000 |
|
Julie A. Dobson |
|
|
38,978 |
|
|
|
147,500 |
|
Robert E. Keith, Jr. |
|
|
242,589 |
|
|
|
232,000 |
|
Andrew E. Lietz |
|
|
12,500 |
|
|
|
180,000 |
|
George MacKenzie |
|
|
12,500 |
|
|
|
169,500 |
|
George D. McClelland |
|
|
141,906 |
|
|
|
125,000 |
|
Jack L. Messman |
|
|
88,387 |
|
|
|
157,000 |
|
John W. Poduska, Sr. |
|
|
12,500 |
|
|
|
157,000 |
|
John J. Roberts |
|
|
39,279 |
|
|
|
180,000 |
|
Robert J. Rosenthal |
|
|
12,500 |
|
|
|
75,000 |
|
|
|
|
(4) |
|
These amounts do not represent compensation actually received. Rather, these amounts
represent the aggregate expense we recognized for financial statement reporting purposes for
the fiscal year ended December 31, 2008 for stock options awarded during and prior to 2008, in
accordance with FAS 123(R). In accordance with SEC rules, the amounts shown exclude the
effect of estimated forfeitures related to service-based vesting conditions. The fair value
of the stock options is estimated at the date of grant using the Black-Scholes option-pricing
model. The grant date fair values of the stock options issued during 2008 were as follows:
each of Ms. Dobson and Messrs. Cody, Keith, Lietz, MacKenzie, McClelland, Messman, Poduska,
Roberts and Rosenthal $14,265. For a discussion of valuation assumptions, see footnote 2 to
the Summary Compensation Table under the heading Executive Compensation. |
|
(5) |
|
Our equity compensation plans provide for the accelerated vesting of stock options granted to
non-employee directors upon retirement from the Board on or after their 65th
birthday, and deferred stock units also are fully vested once a director reaches age 65.
Messrs. Keith, Lietz, Messman and Poduska have each reached age 65. In accordance with FAS
123(R), the amounts shown for these four directors include the entire expense for all grants
awarded to them during 2008. |
|
(6) |
|
The amounts in this column represent reimbursement of expenses incurred by these directors
for attendance at a directors continuing education program or a directors reasonable annual
dues for a membership organization focused on director education. |
|
(7) |
|
Directors also are eligible for reimbursement of expenses incurred in connection with
attendance at Board and Committee meetings. These amounts are not included in the table
above. |
|
|
|
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters |
SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS
Our equity compensation plans provide a broad-based program designed to attract and retain talent
while creating alignment with the long-term interests of our shareholders. Employees at all levels
participate in our equity compensation plans. In addition, members of our Board of Directors
(Board) and members of our Technology and Life Sciences Advisory Boards (Advisory Boards)
receive stock options for their service on our Board and Advisory Boards, respectively. Members of
our Board also receive deferred stock unit awards and are eligible to defer directors fees and
receive deferred stock units with a value equal to the directors fees deferred and matching
deferred stock units equal to 25% of the directors fees deferred.
Our Board is authorized to administer our equity compensation plans, adopt, amend and repeal the
administrative rules relating to the plans, and interpret the provisions of the plans. Our Board
has delegated to the Compensation Committee of the Board (the Compensation Committee) authority
to administer our equity compensation plans.
34
Our Compensation Committee has the authority to select the recipients of grants under our equity
compensation plans and determine the terms and conditions of the grants, including but not limited
to (i) the number of shares of common stock covered by such grants; (ii) the type of grant;
(iii) the dates or events upon which such grants vest; (iv) the exercise price of options (which is
equal to the average of the high and low prices of a share of our common
stock as reported on the New York Stock Exchange composite tape on the grant date) or the
consideration to be paid in connection with restricted stock, stock units or other stock-based
grants (which may be no consideration); and (iv) the term of the grant. Stock options typically
vest as follows: (i) time-based stock options vest 25% on the first anniversary of the grant date
and in 36 equal monthly installments thereafter; (ii) market-based stock options vest upon the
achievement of certain specified levels of improvement in Safeguards stock price; and (iii)
performance-based stock options vest based upon the aggregate cash produced as a result of exit
transactions involving certain of our partner companies relative to the amount of cash deployed in
connection with such partner companies. Deferred stock units issued to directors are payable, on a
one-for-one basis, in shares of Safeguard common stock following a directors termination of
service on the Board. Deferred stock units issued to directors in lieu of cash compensation are
fully vested at grant; deferred stock unit awards and matching deferred stock units awarded to
directors generally vest on the first anniversary of the grant date.
The 2001 Plan provides for the grant of nonqualified stock options, stock appreciation rights,
restricted stock, performance units, and other stock-based awards to employees, consultants or
advisors of Safeguard and its subsidiaries, provided that no grants can be made under this plan to
executive officers and directors of Safeguard. Under the NYSE rules that were in effect at the time
this plan was adopted in 2001, shareholder approval of the plan was not required. This plan is
administered by the Compensation Committee which, as described above, has the authority to issue
equity grants under the 2001 Plan and to establish the terms and conditions of such grants. Except
for the persons eligible to participate in the 2001 Plan and the inability to grant incentive stock
options under the 2001 Plan, the terms of the 2001 plan are substantially the same as the other
equity compensation plans approved by our shareholders (which have been described in previous
filings).
A total of 5,400,000 shares of our common stock are authorized for issuance under the 2001 Plan. At
December 31, 2008, 1,865,544 shares were subject to outstanding options, 1,803,809 shares were
available for future issuance, and 1,730,647 shares had been issued under the 2001 Plan. If any
option granted under the 2001 Plan expires or is terminated, surrendered, canceled or forfeited, or
if any shares of restricted stock, performance units or other stock-based grants are forfeited, the
unused shares of common stock covered by such grants will again be available for grant under the
2001 Plan.
Our Board is authorized to make appropriate adjustments in connection with the 2001 Plan to reflect
any stock split, stock dividend, recapitalization, liquidation, spin-off or other similar event.
The 2001 Plan also contains provisions addressing the consequences of any Reorganization Event or
Change in Control (as such terms are defined in the 2001 Plan). If a Reorganization or Change of
Control Event occurs, unless the Compensation Committee determines otherwise, all outstanding
options and stock appreciation rights (SARs) that are not exercised will be assumed by, or replaced
with comparable options or rights by, the surviving corporation (or a parent of the surviving
corporation), and other outstanding grants will be converted to similar grants of the surviving
corporation or a parent of the surviving corporation). Notwithstanding that provision, the
Compensation Committee has the authority to take one or both of the following actions: (i) require
that grantees surrender their outstanding options and SARs in exchange for a payment by Safeguard
in cash or company stock, as determined by the Compensation Committee, in an amount equal to the
amount by which the then fair market value of the shares of stock subject to the unexercised
options and SARs exceeds the exercise price of the options or the base amount of the SARs, as
applicable, or (ii) after giving grantees an opportunity to exercise their outstanding options and
SARs or otherwise realize the value of all of their other grants, terminate any or all unexercised
options, SARs and grants at such time as the Compensation Committee deems appropriate.
35
During
2005, the Compensation Committee granted employee inducement awards to two newly hired
executive officers. The awards were granted outside of Safeguards existing equity compensation
plans in accordance with NYSE rules and consisted of options to purchase up to an aggregate of
6,000,000 shares of Safeguard common stock. During 2007 and 2008, the Compensation Committee
granted similar employee inducement awards to two other and one other, respectively, newly hired
executive officers. These awards were likewise granted outside of Safeguards existing equity
compensation plans in accordance with NYSE rules and consisted of options to purchase up to an
aggregate of 4,000,000 shares of Safeguard common stock. All of these employee inducement awards
were granted with an eight-year term and a per share exercise price equal to the average of the
high and low prices of Safeguard common stock on the grant date. Following his termination of
employment in May 2008, the employment inducement awards held by one of the executive officers to
whom inducement grants were awarded in 2007, for an aggregate of 1,500,000 shares of Safeguard
common stock, expired without value. Of the shares
underlying the employee inducement awards that were outstanding at December 31, 2008,
2,125,000 shares are subject to time-based vesting, with an aggregate of 531,250 shares vesting on
the first anniversary of the grant date and 1,593,750 shares vesting in 36 equal monthly
installments thereafter. The remaining 6,375,000 shares underlying the employee inducement awards
that were outstanding at December 31, 2008, vest incrementally based upon the achievement of
certain specified levels of increase in Safeguards stock price. With the exception of the
market-based vesting provisions, the terms and provisions of the employee inducement awards are
substantially the same as options previously awarded to other executives under Safeguards equity
compensation plans.
The following table provides information as of December 31, 2008, about the securities authorized
for issuance under our equity compensation plans.
Equity Compensation Plan Information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities |
|
|
|
|
|
|
|
|
|
|
|
Remaining Available for |
|
|
|
Number of Securities to |
|
|
Weighted-Average |
|
|
Future Issuance Under |
|
|
|
Be Issued Upon Exercise |
|
|
Exercise Price of |
|
|
Equity Compensation Plans |
|
|
|
of Outstanding Options, |
|
|
Outstanding Options, |
|
|
(Excluding Securities |
|
|
|
Warrants and Rights |
|
|
Warrants and Rights (1) |
|
|
Reflected in Column (a)) |
|
Plan Category |
|
(a) |
|
|
(b) |
|
|
(c) |
|
Equity compensation
plans approved by
security holders
(2) |
|
|
10,735,307 |
|
|
$ |
1.7922 |
|
|
|
1,737,471 |
|
Equity compensation
plans not approved
by security holders
(3) |
|
|
10,365,544 |
|
|
$ |
1.5673 |
|
|
|
1,803,809 |
|
Total |
|
|
21,100,851 |
|
|
$ |
1.6757 |
|
|
|
3,541,280 |
|
|
|
|
(1) |
|
The weighted average exercise price calculation excludes
1,086,141 shares underlying outstanding deferred stock units included
in column (a) which are payable in stock, on a one-for-one basis. |
|
(2) |
|
Represents awards granted, and shares available for issuance, under
the 1999 Equity Compensation Plan and the 2004 Equity Compensation
Plan. The 1999 Equity Compensation Plan expired by its terms on
February 10, 2009. Includes 695,230 shares underlying deferred stock
units awarded for no consideration and 390,911 shares underlying
deferred stock units awarded to directors in lieu of all or a portion
of directors fees. Payments in respect of deferred stock units are
generally distributable following termination of employment or
service, death, permanent disability or retirement. The value of the
deferred stock units was approximately $2.2 million based on the fair
value of the stock on the various grant dates. The deferred stock
units issued to directors in lieu of cash compensation are fully
vested at grant; deferred stock unit awards and matching deferred
stock units awarded to directors generally vest on the first
anniversary of the grant date. |
|
(3) |
|
Includes awards granted and shares available for issuance under the
2001 Plan and 8,500,000 employee inducement awards. |
36
STOCK OWNERSHIP OF CERTAIN BENEFICIAL OWNERS, DIRECTORS AND OFFICERS
The following table shows the number of shares of Safeguard common stock beneficially owned (unless
otherwise indicated) as of April 15, 2009, by each person known to us to be the beneficial owner of
more than 5% of our outstanding shares of common stock, our directors, persons named in the Summary
Compensation Table in this proxy statement, and our directors and current executive officers as a
group. For purposes of reporting total beneficial ownership, shares that may be acquired within 60
days of April 15, 2009 through the exercise of Safeguard stock options are included. On April 15,
2009, there were 122,029,312 shares of common stock outstanding and 4,704,358 shares underlying
stock options held by executive officers and directors as a group that were exercisable within 60
days of April 15, 2009.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding |
|
|
|
|
|
|
Beneficially |
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares |
|
|
Options |
|
|
Owned Assuming |
|
|
Percent of |
|
|
Other Stock-Based |
|
|
|
Beneficially |
|
|
Exercisable |
|
|
Exercise of |
|
|
Outstanding |
|
|
Holdings (2) |
|
Name |
|
Owned |
|
|
Within 60 Days |
|
|
Options |
|
|
Shares (1) |
|
|
Vested |
|
|
Unvested |
|
Dimensional Fund Advisors LP
|
|
|
6,471,267 |
|
|
|
|
|
|
|
6,471,267 |
|
|
|
5.3 |
% |
|
|
|
|
|
|
|
|
1299 Ocean
Avenue Santa Monica, CA 90401 (3) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
T. Rowe Price Associates, Inc.
|
|
|
6,375,402 |
|
|
|
|
|
|
|
6,375,402 |
|
|
|
5.2 |
% |
|
|
|
|
|
|
|
|
100 East Pratt Street |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Baltimore, MD 21202 (4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Peter J. Boni |
|
|
585,144 |
|
|
|
1,798,745 |
|
|
|
2,383,889 |
|
|
|
1.9 |
% |
|
|
|
|
|
|
|
|
Michael J. Cody |
|
|
7,500 |
|
|
|
75,000 |
|
|
|
82,500 |
|
|
|
* |
|
|
|
|
|
|
|
12,500 |
|
Julie A. Dobson |
|
|
40,500 |
|
|
|
122,500 |
|
|
|
163,000 |
|
|
|
* |
|
|
|
30,587 |
|
|
|
16,625 |
|
Robert E. Keith, Jr. |
|
|
153,366 |
|
|
|
207,000 |
|
|
|
360,366 |
|
|
|
* |
|
|
|
251,822 |
|
|
|
21,536 |
|
Andrew E. Lietz |
|
|
45,000 |
|
|
|
155,000 |
|
|
|
200,000 |
|
|
|
* |
|
|
|
|
|
|
|
12,500 |
|
George MacKenzie |
|
|
10,500 |
|
|
|
144,500 |
|
|
|
155,000 |
|
|
|
* |
|
|
|
|
|
|
|
12,500 |
|
George D. McClelland |
|
|
10,000 |
|
|
|
75,000 |
|
|
|
85,000 |
|
|
|
* |
|
|
|
151,190 |
|
|
|
34,466 |
|
Jack L. Messman |
|
|
38,000 |
|
|
|
132,000 |
|
|
|
170,000 |
|
|
|
* |
|
|
|
93,782 |
|
|
|
21,047 |
|
John W. Poduska, Sr. |
|
|
12,500 |
|
|
|
132,000 |
|
|
|
144,500 |
|
|
|
* |
|
|
|
|
|
|
|
12,500 |
|
John J. Roberts |
|
|
|
|
|
|
155,000 |
|
|
|
155,000 |
|
|
|
* |
|
|
|
26,779 |
|
|
|
12,500 |
|
Robert J. Rosenthal |
|
|
|
|
|
|
12,500 |
|
|
|
12,500 |
|
|
|
* |
|
|
|
|
|
|
|
12,500 |
|
James A. Datin |
|
|
405,626 |
|
|
|
899,372 |
|
|
|
1,304,998 |
|
|
|
1.1 |
% |
|
|
|
|
|
|
|
|
Kevin L. Kemmerer |
|
|
243,200 |
|
|
|
495,748 |
|
|
|
738,948 |
|
|
|
* |
|
|
|
|
|
|
|
|
|
Brian J. Sisko |
|
|
202,834 |
|
|
|
149,993 |
|
|
|
352,827 |
|
|
|
* |
|
|
|
|
|
|
|
|
|
Stephen T. Zarrilli |
|
|
74,000 |
|
|
|
150,000 |
|
|
|
224,000 |
|
|
|
* |
|
|
|
|
|
|
|
|
|
Raymond J. Land (5) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
|
|
|
|
|
|
|
|
Executive officers and
directors
as a group (15 persons) (6) |
|
|
1,828,170 |
|
|
|
4,704,358 |
|
|
|
6,532,528 |
|
|
|
5.2 |
% |
|
|
554,160 |
|
|
|
168,674 |
|
|
|
|
(1) |
|
Each director and named executive officer has the sole power to vote and to dispose of the
shares (other than shares held jointly with an individuals spouse) except 900 shares held by
Mr. Keiths spouse, as to which Mr. Keith disclaims beneficial ownership. An * indicates
ownership of less than 1% of the outstanding shares. |
|
(2) |
|
The shares in this column represent deferred stock units that have been credited to each
individual. The deferred stock units, which may not be voted or transferred, are payable, on
a one-for-one basis, in shares of Safeguard common stock following an individuals termination
of service on the Safeguard Board. See Director Compensation. |
|
(3) |
|
As reflected in Schedule 13G filed with the Securities and Exchange Commission, Dimensional
Fund Advisors LP (Dimensional) is a registered investment advisor which furnishes investment
advice to four investment companies and serves as investment manager to certain other
commingled group trusts and separate accounts (the Funds). In its role, Dimensional
possesses investment and/or voting power over the securities held by the Funds and may be
deemed to have beneficial ownership of such shares. Dimensional disclaims beneficial
ownership of such shares. |
|
(4) |
|
As reflected in Schedule 13G filed with the Securities and Exchange Commission, these
securities are owned by various individual and institutional investors for which T. Rowe Price
Associates, Inc. (Price Associates) serves as investment adviser with power to direct
investments and/or sole power to vote the securities. For purposes of the reporting
requirements of the Securities Exchange Act of 1934, Price Associates is deemed to be a
beneficial owner of such securities; however, Price Associates expressly disclaims that it is,
in fact, the beneficial owner of such securities. |
|
(5) |
|
Mr. Land voluntarily resigned as a Safeguard employee in May 2008. |
|
(6) |
|
Excludes Mr. Land, who resigned in May 2008. |
37
As of April 15, 2009, the current executive officers and directors of Safeguard owned less than 1%
of the shares of common stock outstanding of Clarient, Inc., a publicly traded partner company of
Safeguard. The executive officers and directors of Safeguard did not own shares of any other
Safeguard subsidiary.
Item 13. Certain Relationships and Related Transactions, and Director Independence
Review and Approval of Transactions with Related Persons. The Board has adopted a written policy
which charges the Audit Committee with the responsibility of reviewing with management at each
regularly scheduled meeting and determining whether to approve any transaction (other than a
transaction that is available to all employees generally on a non-discriminatory basis) between us
and our directors, director nominees and executive officers or their immediate family members.
Between regularly scheduled meetings of the Audit Committee, management may preliminarily approve a
related party transaction, subject to ratification of the transaction by the Audit Committee. If
the Audit Committee does not ratify the transaction, management will make all reasonable efforts to
cancel the transaction.
Relationships And Related Transactions With Management And Others
As part of our business, we have in the past participated in the management of private equity
funds. Robert E. Keith, Jr., Chairman of our Board, is the President and Chief Executive Officer
of TL Ventures, the management company for TL Ventures III, TL Ventures IV, and TL Ventures V, and
the Chairman of the management companies for EnerTech Capital Partners and EnerTech Capital
Partners II. In December 2005, Safeguard sold substantially all of its interests in TL Ventures
and EnerTech Capital Partners funds for approximately $24 million in cash with the buyers also
assuming approximately $9 million of Safeguards remaining unfunded capital commitments to these
funds. Safeguard retained certain limited rights and obligations related primarily to its former
role as a general partner of some of the funds. Under certain circumstances, we may be required to
return a portion or all the distributions we received as a general partner of a fund for further
distribution to such funds limited partners (the clawback). The Company paid $3.0 million of
its estimated clawback liabilities in 2008. Assuming for these purposes only that the funds were
liquidated or dissolved on December 31, 2008 and the only distributions from the funds were equal
to the carrying value of the funds on the December 31, 2008 financial statements, the maximum
remaining clawback we would be required to return for our general partner interest is $2.5 million.
Director Independence
In accordance with the guidelines set forth above in Item 10 under the caption Board
Independence, the Board has determined that Michael Cody, Julie Dobson, Andrew Lietz, George
MacKenzie, George McClelland, Jack Messman, John Poduska, John Roberts and Robert Rosenthal have no
direct or indirect material relationships with us other than their directorship and, therefore, are
independent within the meaning of the NYSE listing standards and satisfy the categorical standards
contained in our Corporate Governance Guidelines.
38
Item 14. Principal Accountant Fees and Services
Independent Registered Public Accounting FirmAudit Fees
The following table presents fees for professional services rendered by KPMG LLP for the audit of
Safeguards consolidated financial statements for fiscal 2008 and fiscal 2007 and fees billed for
audit-related services, tax services and all other services rendered by KPMG for fiscal 2008 and
fiscal 2007. This table includes fees billed to Safeguards consolidated subsidiaries for services
rendered by KPMG.
|
|
|
|
|
|
|
|
|
|
|
2008 |
|
|
2007 |
|
Audit Fees (1) |
|
$ |
1,317,691 |
|
|
$ |
2,148,774 |
|
Audit-Related Fees (2) |
|
|
|
|
|
|
17,500 |
|
Tax Fees (3) |
|
|
282,606 |
|
|
|
331,740 |
|
All Other Fees |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
1,600,297 |
|
|
$ |
2,498,014 |
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Audit fees include the aggregate fees for professional services rendered in connection with
the audit of the consolidated financial statements included in our Annual Report on Form
10-K, the review of the condensed consolidated financial statements included in our Quarterly
Reports on Form 10-Q, consents and other services related to SEC and other regulatory
filings, and KPMGs assurance services provided in connection with the assessment and testing
of internal controls over financial reporting pursuant to Section 404 of the Sarbanes Oxley
Act of 2002. |
|
(2) |
|
Audit-related fees include the aggregate fees billed by KPMG principally for audits of
financial statements of certain employee benefit plans, statutory audits of non-U.S.
subsidiaries and officer expense review. |
|
(3) |
|
Tax fees include the aggregate fees billed by KPMG for tax consultation and tax compliance
services. |
The Audit Committee pre-approves each service to be performed by KPMG at its regularly scheduled
meetings. For any service that may require pre-approval between regularly scheduled meetings, the
Audit Committee has delegated to the Chairperson of the Audit Committee the authority to
pre-approve services not prohibited by law to be performed by Safeguards independent registered
public accounting firm and associated fees up to a maximum
for such services of $100,000, and the Chairperson communicates such pre-approvals to the
Audit Committee at its next regularly scheduled meeting.
PART IV
Item 15. Exhibits and Financial Statement Schedules
(a) Consolidated Financial Statements and Schedules
Incorporated by reference to Item 8 of this Report on Form 10-K.
(b) Exhibits
The exhibits required to be filed as part of this Report are listed in the exhibit index
below.
Exhibits
The following is a list of exhibits required by Item 601 of Regulation S-K filed as part of
this Report. For exhibits that previously have been filed, the Registrant incorporates those
exhibits herein by reference. The exhibit table below includes the Form Type and Filing Date of the
previous filing and the location of the exhibit in the previous filing which is being incorporated
by reference herein. Documents which are incorporated by reference to filings by parties other than
the Registrant are identified in footnotes to this table.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incorporated Filing Reference |
|
|
|
|
Form Type & |
|
|
Exhibit |
|
|
|
Filing |
|
Original |
Number |
|
Description |
|
Date |
|
Exhibit Number |
2.1.1
|
|
Purchase Agreement, dated as of February 29, 2008, by and
between Safeguard Scientifics, Inc., as Seller, and Saints
Capital Dakota, L.P., as Purchaser.
|
|
Form 8-K
3/4/08
|
|
|
2.1 |
|
|
|
|
|
|
|
|
|
|
|
|
2.1.2
|
|
First Amendment to Purchase Agreement, dated May 6, 2008,
by and between Safeguard Scientifics, Inc., as Seller, and
Saints Capital Dakota, L.P., as Purchaser
|
|
Form 8-K
5/7/08
|
|
|
2.1 |
|
|
|
|
|
|
|
|
|
|
|
|
3.1
|
|
Seconded Amended and Restated Articles of Incorporation of
Safeguard Scientifics, Inc.
|
|
Form 8-K
10/25/07
|
|
|
3.1 |
|
|
|
|
|
|
|
|
|
|
|
|
3.2
|
|
Amended and Restated By-laws of Safeguard Scientifics, Inc.
|
|
Form 8-K
10/25/07
|
|
|
3.2 |
|
|
|
|
|
|
|
|
|
|
|
|
4.1
|
|
Rights Agreement dated as of March 1, 2000 between
Safeguard Scientifics, Inc. and ChaseMellon Shareholder
Services LLC, as Rights Agent
|
|
Form 8-K
2/29/00
|
|
|
4 |
|
|
|
|
|
|
|
|
|
|
|
|
39
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.2
|
|
Indenture, dated as of February 18, 2004 between Safeguard
Scientifics, Inc. and Wachovia Bank, National Association,
as trustee, including the form of 2.625% Convertible
Senior Debentures due 2024
|
|
Form 10-K
3/15/04
|
|
|
4.10 |
|
|
|
|
|
|
|
|
|
|
|
|
10.1*
|
|
Safeguard Scientifics, Inc. 1999 Equity Compensation Plan,
as amended and restated on October 21, 2008
|
|
Form 10-Q
11/6/08
|
|
|
10.4 |
|
|
|
|
|
|
|
|
|
|
|
|
10.2
|
|
Safeguard Scientifics, Inc. 2001 Associates Equity
Compensation Plan, as amended and restated on October 21,
2008
|
|
Form 10-Q
11/6/08
|
|
|
10.5 |
|
|
|
|
|
|
|
|
|
|
|
|
10.3*
|
|
Safeguard Scientifics, Inc. 2004 Equity Compensation Plan,
as amended and restated on October 21, 2008
|
|
Form 10-Q
11/6/08
|
|
|
10.6 |
|
|
|
|
|
|
|
|
|
|
|
|
10.4*
|
|
Safeguard Scientifics, Inc. Executive Deferred
Compensation Plan (amended and restated as of January 1,
2009)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.5*
|
|
Management Incentive Plan
|
|
Form 8-K
4/25/08
|
|
|
10.1 |
|
|
|
|
|
|
|
|
|
|
|
|
10.6*
|
|
Compensation Summary Non-employee Directors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.7*
|
|
Amended and Restated Agreement by and between Safeguard
Scientifics, Inc. and Peter J. Boni dated December 5, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.8*
|
|
Amended and Restated Agreement by and between Safeguard
Scientifics, Inc. and James A. Datin dated December 31,
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.9.1*
|
|
Agreement by and between Safeguard Scientifics, Inc. and
Stephen Zarrilli dated as of May 28, 2008
|
|
Form 8-K
5/29/08
|
|
|
10.1 |
|
|
|
|
|
|
|
|
|
|
|
|
10.9.2*
|
|
Letter Amendment dated December 9, 2008 to Agreement by
and between Safeguard Scientifics, Inc. and Stephen
Zarrilli dated as of May 28, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.10*
|
|
Agreement by and between Safeguard Scientifics, Inc. and
Raymond J. Land dated May 24, 2007
|
|
Form 8-K
6/11/07
|
|
|
99.1 |
|
|
|
|
|
|
|
|
|
|
|
|
10.11*
|
|
Agreement by and between Safeguard Scientifics, Inc. and
Kevin L. Kemmerer dated December 29, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.12*
|
|
Amended and Restated Letter Agreement by and between
Safeguard Scientifics, Inc. and Brian J. Sisko dated
December 3, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.13.1
|
|
Amended and Restated Loan and Security Agreement dated as
of June 30, 2008 by and among Comerica Bank, Safeguard
Delaware, Inc. and Safeguard Scientifics (Delaware), Inc.
|
|
Form 8-K
7/2/08
|
|
|
10.1 |
|
|
|
|
|
|
|
|
|
|
|
|
10.13.2
|
|
Amendment and Affirmation of Guaranty from Safeguard
Scientifics, Inc. to Comerica Bank dated as of June 30,
2008
|
|
Form 10-Q
8/11/08
|
|
|
10.8.2 |
|
|
|
|
|
|
|
|
|
|
|
|
10.14.1
|
|
Amended and Restated Loan Agreement dated as of February
28, 2008, by and between Comerica Bank and Clarient, Inc.
|
|
Form 8-K
3/5/08
|
|
|
10.1 |
|
|
|
|
|
|
|
|
|
|
|
|
10.14.2
|
|
First Amendment and Waiver to Amended and Restated Loan
Agreement, dated as of March 14, 2008, by and between
Comerica Bank and Clarient, Inc.
|
|
|
(4 |
) |
|
|
10.2 |
|
|
|
|
|
|
|
|
|
|
|
|
10.14.3
|
|
Second Amendment to Amended and Restated Loan Agreement,
dated as of March 21, 2008, by and between Comerica Bank
and Clarient, Inc.
|
|
|
(3 |
) |
|
|
10.82 |
|
|
|
|
|
|
|
|
|
|
|
|
10.14.4
|
|
Third Amendment and Consent to Amended and Restated Loan
Agreement, dated as of July 31, 2008, by and between
Comerica Bank and Clarient, Inc.
|
|
|
(5 |
) |
|
|
10.2 |
|
|
|
|
|
|
|
|
|
|
|
|
10.14.5
|
|
Fourth Amendment to Amended and Restated Loan Agreement,
dated as of January 27, 2009, by and between Comerica Bank
and Clarient, Inc.
|
|
|
(6 |
) |
|
|
10.2 |
|
|
|
|
|
|
|
|
|
|
|
|
10.14.6
|
|
Fifth Amendment to Amended and Restated Loan Agreement
dated February 27, 2009, by and between Clarient, Inc. and
Comerica Bank
|
|
|
(7 |
) |
|
|
10.2 |
|
|
|
|
|
|
|
|
|
|
|
|
10.14.7
|
|
Third Amended and Restated Unconditional Guaranty dated
January 17, 2007 to Comerica Bank provided by Safeguard
Delaware, Inc. and Safeguard Scientifics (Delaware), Inc.
(on behalf of Clarient, Inc.)
|
|
|
(1 |
) |
|
|
10.2 |
|
|
|
|
|
|
|
|
|
|
|
|
10.14.8
|
|
Amended and Restated Reimbursement and Indemnity Agreement
dated as of January 17, 2007, by Clarient, Inc. in favor
of Safeguard Delaware, Inc. and Safeguard Scientifics
(Delaware), Inc.
|
|
|
(1 |
) |
|
|
10.3 |
|
|
|
|
|
|
|
|
|
|
|
|
10.14.9
|
|
Amendment and Affirmation of Guaranty dated February 28,
2007 to Comerica Bank provided by Safeguard Delaware, Inc.
and Safeguard Scientifics (Delaware), Inc. (on behalf of
Clarient, Inc.)
|
|
|
(1 |
) |
|
|
10.5 |
|
|
|
|
|
|
|
|
|
|
|
|
10.15.1
|
|
Securities Purchase Agreement dated November 8, 2005 by
and among Clarient, Inc. and the investors named therein
|
|
|
(2 |
) |
|
|
99.1 |
|
|
|
|
|
|
|
|
|
|
|
|
10.15.2
|
|
Form of Common Stock Purchase Warrant issued by Clarient,
Inc. pursuant to the Securities Purchase Agreement dated
November 8, 2005
|
|
|
(2 |
) |
|
|
99.3 |
|
|
|
|
|
|
|
|
|
|
|
|
10.16.1
|
|
Second Amended and Restated Senior Subordinated Revolving
Credit Agreement dated February 27, 2009 by and between
Safeguard Delaware, Inc. and Clarient, Inc.
|
|
|
(7 |
) |
|
|
10.3 |
|
|
|
|
|
|
|
|
|
|
|
|
10.17
|
|
Amended and Restated Registration Rights Agreement dated
February 27, 2009 by and among Safeguard Delaware, Inc.,
Safeguard Scientifics, Inc., Safeguard Scientifics
(Delaware), Inc. and Clarient, Inc.
|
|
|
(7 |
) |
|
|
10.4 |
|
|
|
|
|
|
|
|
|
|
|
|
10.18
|
|
Letter of Credit issued to W.P. Carey
|
|
Form 8-K
10/5/04
|
|
|
10.1 |
|
|
|
|
|
|
|
|
|
|
|
|
10.19
|
|
Purchase and Sale Agreement dated as of December 9, 2005
by and among HarbourVest VII Venture Ltd., Dover Street VI
L.P. and several subsidiaries and affiliated limited
partnerships of Safeguard Scientifics, Inc.
|
|
Form 10-K
3/13/06
|
|
|
10.36 |
|
|
|
|
|
|
|
|
|
|
|
|
14.1
|
|
Code of Business Conduct and Ethics
|
|
Form 10-Q
11/6/08
|
|
|
14.1 |
|
|
|
|
|
|
|
|
|
|
|
|
21.1
|
|
List of Subsidiaries
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.1
|
|
Consent of Independent Registered Public Accounting Firm
KPMG LLP
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.1
|
|
Certification of Peter J. Boni pursuant to Rules 13a-15(e)
and 15d-15(e) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.2
|
|
Certification of Stephen T. Zarrilli pursuant to Rules
13a-15(e) and 15d-15(e) of the Securities Exchange Act of
1934
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.3
|
|
Certification of Peter J. Boni pursuant to Rules 13a-15(e)
and 15d-15(e) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.4
|
|
Certification of Stephen T. Zarrilli pursuant to Rules
13a-15(e) and 15d-15(e) of the Securities Exchange Act of
1934
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.1
|
|
Certification of Peter J. Boni pursuant to 18 U.S.C.
Section 1350, as Adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.2
|
|
Certification of Stephen T. Zarrilli pursuant to 18 U.S.C.
Section 1350, as Adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
|
|
|
Filed on March 19, 2009 as an Exhibit to Form 10-K. |
|
|
|
Filed on April 29, 2009 as an Exhibit to Amendment No. 1 on Form 10-K/A |
|
* |
|
These exhibits relate to management contracts or compensatory plans, contracts or arrangements in which directors and/or executive
officers of the Registrant may participate. |
|
(1) |
|
Incorporated by reference to the Quarterly Report on Form 10-Q filed on May 9, 2007 by Clarient, Inc. (SEC File No. 000-22677) |
|
(2) |
|
Incorporated by reference to the Current Report on Form 8-K filed on November 9, 2005 by Clarient, Inc. (SEC File No. 000-22677) |
|
(3) |
|
Incorporated by reference to the Annual Report on Form 10-K filed on April 1, 2008 by Clarient, Inc. (SEC File No. 000-226770) |
|
(4) |
|
Incorporated by reference to the Quarterly Report on Form 10-Q filed on May 16, 2008 by Clarient, Inc. (SEC File No. 000-22677) |
|
(5) |
|
Incorporated by reference to the Current Report on Form 8-K filed on August 5, 2008 by Clarient, Inc. (SEC File No. 000-22677) |
|
(6) |
|
Incorporated by reference to the Current Report on Form 8-K filed on February 2, 2009 by Clarient, Inc. (SEC File No. 000-22677) |
|
(7) |
|
Incorporated by reference to the Current Report on Form 8-K filed on March 2, 2009 by Clarient, Inc. (SEC File No. 000-22677) |
INCORPORATION BY REFERENCE
To the extent that this Amendment No. 1 is incorporated by reference into any other filing by us
under the Securities Act of 1933 or the Securities Exchange Act of 1934, the section of this
Amendment No. 1 entitled Compensation Committee Report, to the extent permitted by the rules of
the SEC, will not be deemed incorporated unless specifically provided otherwise in such filing.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
|
|
|
|
|
Safeguard Scientifics, Inc.
|
|
|
By: |
PETER J. BONI
|
|
|
|
PETER J. BONI |
|
|
|
President and Chief Executive Officer |
|
Dated: April 29, 2009
40
EXHIBIT
INDEX
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incorporated Filing Reference |
|
|
|
|
Form Type & |
|
|
Exhibit |
|
|
|
Filing |
|
Original |
Number |
|
Description |
|
Date |
|
Exhibit Number |
2.1.1
|
|
Purchase Agreement, dated as of February 29, 2008, by and
between Safeguard Scientifics, Inc., as Seller, and Saints
Capital Dakota, L.P., as Purchaser.
|
|
Form 8-K
3/4/08
|
|
|
2.1 |
|
|
|
|
|
|
|
|
|
|
|
|
2.1.2
|
|
First Amendment to Purchase Agreement, dated May 6, 2008,
by and between Safeguard Scientifics, Inc., as Seller, and
Saints Capital Dakota, L.P., as Purchaser
|
|
Form 8-K
5/7/08
|
|
|
2.1 |
|
|
|
|
|
|
|
|
|
|
|
|
3.1
|
|
Seconded Amended and Restated Articles of Incorporation of
Safeguard Scientifics, Inc.
|
|
Form 8-K
10/25/07
|
|
|
3.1 |
|
|
|
|
|
|
|
|
|
|
|
|
3.2
|
|
Amended and Restated By-laws of Safeguard Scientifics, Inc.
|
|
Form 8-K
10/25/07
|
|
|
3.2 |
|
|
|
|
|
|
|
|
|
|
|
|
4.1
|
|
Rights Agreement dated as of March 1, 2000 between
Safeguard Scientifics, Inc. and ChaseMellon Shareholder
Services LLC, as Rights Agent
|
|
Form 8-K
2/29/00
|
|
|
4 |
|
|
|
|
|
|
|
|
|
|
|
|
4.2
|
|
Indenture, dated as of February 18, 2004 between Safeguard
Scientifics, Inc. and Wachovia Bank, National Association,
as trustee, including the form of 2.625% Convertible
Senior Debentures due 2024
|
|
Form 10-K
3/15/04
|
|
|
4.10 |
|
|
|
|
|
|
|
|
|
|
|
|
10.1*
|
|
Safeguard Scientifics, Inc. 1999 Equity Compensation Plan,
as amended and restated on October 21, 2008
|
|
Form 10-Q
11/6/08
|
|
|
10.4 |
|
|
|
|
|
|
|
|
|
|
|
|
10.2
|
|
Safeguard Scientifics, Inc. 2001 Associates Equity
Compensation Plan, as amended and restated on October 21,
2008
|
|
Form 10-Q
11/6/08
|
|
|
10.5 |
|
|
|
|
|
|
|
|
|
|
|
|
10.3*
|
|
Safeguard Scientifics, Inc. 2004 Equity Compensation Plan,
as amended and restated on October 21, 2008
|
|
Form 10-Q
11/6/08
|
|
|
10.6 |
|
|
|
|
|
|
|
|
|
|
|
|
10.4*
|
|
Safeguard Scientifics, Inc. Executive Deferred
Compensation Plan (amended and restated as of January 1,
2009)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.5*
|
|
Management Incentive Plan
|
|
Form 8-K
4/25/08
|
|
|
10.1 |
|
|
|
|
|
|
|
|
|
|
|
|
10.6*
|
|
Compensation Summary Non-employee Directors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.7*
|
|
Amended and Restated Agreement by and between Safeguard
Scientifics, Inc. and Peter J. Boni dated December 5, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.8*
|
|
Amended and Restated Agreement by and between Safeguard
Scientifics, Inc. and James A. Datin dated December 31,
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.9.1*
|
|
Agreement by and between Safeguard Scientifics, Inc. and
Stephen Zarrilli dated as of May 28, 2008
|
|
Form 8-K
5/29/08
|
|
|
10.1 |
|
|
|
|
|
|
|
|
|
|
|
|
10.9.2*
|
|
Letter Amendment dated December 9, 2008 to Agreement by
and between Safeguard Scientifics, Inc. and Stephen
Zarrilli dated as of May 28, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.10*
|
|
Agreement by and between Safeguard Scientifics, Inc. and
Raymond J. Land dated May 24, 2007
|
|
Form 8-K
6/11/07
|
|
|
99.1 |
|
|
|
|
|
|
|
|
|
|
|
|
10.11*
|
|
Agreement by and between Safeguard Scientifics, Inc. and
Kevin L. Kemmerer dated December 29, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.12*
|
|
Amended and Restated Letter Agreement by and between
Safeguard Scientifics, Inc. and Brian J. Sisko dated
December 3, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.13.1
|
|
Amended and Restated Loan and Security Agreement dated as
of June 30, 2008 by and among Comerica Bank, Safeguard
Delaware, Inc. and Safeguard Scientifics (Delaware), Inc.
|
|
Form 8-K
7/2/08
|
|
|
10.1 |
|
|
|
|
|
|
|
|
|
|
|
|
10.13.2
|
|
Amendment and Affirmation of Guaranty from Safeguard
Scientifics, Inc. to Comerica Bank dated as of June 30,
2008
|
|
Form 10-Q
8/11/08
|
|
|
10.8.2 |
|
|
|
|
|
|
|
|
|
|
|
|
10.14.1
|
|
Amended and Restated Loan Agreement dated as of February
28, 2008, by and between Comerica Bank and Clarient, Inc.
|
|
Form 8-K
3/5/08
|
|
|
10.1 |
|
|
|
|
|
|
|
|
|
|
|
|
10.14.2
|
|
First Amendment and Waiver to Amended and Restated Loan
Agreement, dated as of March 14, 2008, by and between
Comerica Bank and Clarient, Inc.
|
|
|
(4 |
) |
|
|
10.2 |
|
|
|
|
|
|
|
|
|
|
|
|
10.14.3
|
|
Second Amendment to Amended and Restated Loan Agreement,
dated as of March 21, 2008, by and between Comerica Bank
and Clarient, Inc.
|
|
|
(3 |
) |
|
|
10.82 |
|
|
|
|
|
|
|
|
|
|
|
|
10.14.4
|
|
Third Amendment and Consent to Amended and Restated Loan
Agreement, dated as of July 31, 2008, by and between
Comerica Bank and Clarient, Inc.
|
|
|
(5 |
) |
|
|
10.2 |
|
|
|
|
|
|
|
|
|
|
|
|
10.14.5
|
|
Fourth Amendment to Amended and Restated Loan Agreement,
dated as of January 27, 2009, by and between Comerica Bank
and Clarient, Inc.
|
|
|
(6 |
) |
|
|
10.2 |
|
|
|
|
|
|
|
|
|
|
|
|
10.14.6
|
|
Fifth Amendment to Amended and Restated Loan Agreement
dated February 27, 2009, by and between Clarient, Inc. and
Comerica Bank
|
|
|
(7 |
) |
|
|
10.2 |
|
|
|
|
|
|
|
|
|
|
|
|
10.14.7
|
|
Third Amended and Restated Unconditional Guaranty dated
January 17, 2007 to Comerica Bank provided by Safeguard
Delaware, Inc. and Safeguard Scientifics (Delaware), Inc.
(on behalf of Clarient, Inc.)
|
|
|
(1 |
) |
|
|
10.2 |
|
|
|
|
|
|
|
|
|
|
|
|
10.14.8
|
|
Amended and Restated Reimbursement and Indemnity Agreement
dated as of January 17, 2007, by Clarient, Inc. in favor
of Safeguard Delaware, Inc. and Safeguard Scientifics
(Delaware), Inc.
|
|
|
(1 |
) |
|
|
10.3 |
|
|
|
|
|
|
|
|
|
|
|
|
10.14.9
|
|
Amendment and Affirmation of Guaranty dated February 28,
2007 to Comerica Bank provided by Safeguard Delaware, Inc.
and Safeguard Scientifics (Delaware), Inc. (on behalf of
Clarient, Inc.)
|
|
|
(1 |
) |
|
|
10.5 |
|
|
|
|
|
|
|
|
|
|
|
|
10.15.1
|
|
Securities Purchase Agreement dated November 8, 2005 by
and among Clarient, Inc. and the investors named therein
|
|
|
(2 |
) |
|
|
99.1 |
|
|
|
|
|
|
|
|
|
|
|
|
10.15.2
|
|
Form of Common Stock Purchase Warrant issued by Clarient,
Inc. pursuant to the Securities Purchase Agreement dated
November 8, 2005
|
|
|
(2 |
) |
|
|
99.3 |
|
|
|
|
|
|
|
|
|
|
|
|
10.16.1
|
|
Second Amended and Restated Senior Subordinated Revolving
Credit Agreement dated February 27, 2009 by and between
Safeguard Delaware, Inc. and Clarient, Inc.
|
|
|
(7 |
) |
|
|
10.3 |
|
|
|
|
|
|
|
|
|
|
|
|
10.17
|
|
Amended and Restated Registration Rights Agreement dated
February 27, 2009 by and among Safeguard Delaware, Inc.,
Safeguard Scientifics, Inc., Safeguard Scientifics
(Delaware), Inc. and Clarient, Inc.
|
|
|
(7 |
) |
|
|
10.4 |
|
|
|
|
|
|
|
|
|
|
|
|
10.18
|
|
Letter of Credit issued to W.P. Carey
|
|
Form 8-K
10/5/04
|
|
|
10.1 |
|
|
|
|
|
|
|
|
|
|
|
|
10.19
|
|
Purchase and Sale Agreement dated as of December 9, 2005
by and among HarbourVest VII Venture Ltd., Dover Street VI
L.P. and several subsidiaries and affiliated limited
partnerships of Safeguard Scientifics, Inc.
|
|
Form 10-K
3/13/06
|
|
|
10.36 |
|
|
|
|
|
|
|
|
|
|
|
|
14.1
|
|
Code of Business Conduct and Ethics
|
|
Form 10-Q
11/6/08
|
|
|
14.1 |
|
|
|
|
|
|
|
|
|
|
|
|
21.1
|
|
List of Subsidiaries
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.1
|
|
Consent of Independent Registered Public Accounting Firm
KPMG LLP
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.1
|
|
Certification of Peter J. Boni pursuant to Rules 13a-15(e)
and 15d-15(e) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.2
|
|
Certification of Stephen T. Zarrilli pursuant to Rules
13a-15(e) and 15d-15(e) of the Securities Exchange Act of
1934
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.3
|
|
Certification of Peter J. Boni pursuant to Rules 13a-15(e)
and 15d-15(e) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.4
|
|
Certification of Stephen T. Zarrilli pursuant to Rules
13a-15(e) and 15d-15(e) of the Securities Exchange Act of
1934
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.1
|
|
Certification of Peter J. Boni pursuant to 18 U.S.C.
Section 1350, as Adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.2
|
|
Certification of Stephen T. Zarrilli pursuant to 18 U.S.C.
Section 1350, as Adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
|
|
|
Filed on March 19, 2009 as an Exhibit to Form 10-K. |
|
|
|
Filed on April 29, 2009 as an Exhibit to Amendment No. 1 on Form 10-K/A |
|
* |
|
These exhibits relate to management contracts or compensatory plans, contracts or arrangements in which directors and/or executive
officers of the Registrant may participate. |
|
(1) |
|
Incorporated by reference to the Quarterly Report on Form 10-Q filed on May 9, 2007 by Clarient, Inc. (SEC File No. 000-22677) |
|
(2) |
|
Incorporated by reference to the Current Report on Form 8-K filed on November 9, 2005 by Clarient, Inc. (SEC File No. 000-22677) |
|
(3) |
|
Incorporated by reference to the Annual Report on Form 10-K filed on April 1, 2008 by Clarient, Inc. (SEC File No. 000-226770) |
|
(4) |
|
Incorporated by reference to the Quarterly Report on Form 10-Q filed on May 16, 2008 by Clarient, Inc. (SEC File No. 000-22677) |
|
(5) |
|
Incorporated by reference to the Current Report on Form 8-K filed on August 5, 2008 by Clarient, Inc. (SEC File No. 000-22677) |
|
(6) |
|
Incorporated by reference to the Current Report on Form 8-K filed on February 2, 2009 by Clarient, Inc. (SEC File No. 000-22677) |
|
(7) |
|
Incorporated by reference to the Current Report on Form 8-K filed on March 2, 2009 by Clarient, Inc. (SEC File No. 000-22677) |